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Abstract of the Dissertation 
Serum Response Factor (SRF) Regulates Multiple Aspects of Central 
Nervous System Development 
 
by Paul (Puo-Yuan) Lu, Laboratory of Dr. Naren Ramanan.  Department of 
Anatomy & Neurobiology, Washington University School of Medicine 
 
SRF is a highly evolutionary conserved activity-dependent transcription 
factor.  Previous studies have shown that neuron-specific deletion of SRF results in 
deficits in tangential cell migration, guidance-dependent circuit assembly, activity-
dependent gene expression, and synaptic plasticity in the hippocampus.  However, 
very little is known in terms of whether SRF participates in earlier aspects of central 
nervous system development such as neuronal projection establishment, cell-fate 
specifications, and neural stem cell homeostasis and survival.   
We report that SRF is critical for development of major axonal tracts in the 
forebrain. Conditional mutant mice lacking SRF in neural progenitor cells (Srf-
Nestin-cKO) exhibit striking deficits in cortical axonal projections including 
corticostriatal, corticospinal, and corticothalamic tracts, and they show a variable 
loss of the corpus callosum. Neurogenesis and interneuron specification occur 
normally in the absence of SRF and the deficits in axonal projections were not due 
to a decrease or loss in cell numbers.  Similar axonal tract deficits were also 
observed in mutant mice lacking SRF in the developing neurons of neocortex and 
hippocampus (Srf-NEX-cKO).  These findings suggest crucial functional roles for 
SRF during neuronal development; SRF is specifically required in a cell-intrinsic 
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manner for axonal tract development but is dispensable for cell survival, 
neurogenesis, neocortical lamination, and neuronal differentiation. 
  
Furthermore, we found that deletion of SRF in neural precursor cells in Srf-
Nestin-cKO animals results in 40 - 60% loss in astrocytes as well as 
oligodendrocytes precursor cells at birth.  Astrocytes and oligodendrocytes play 
crucial roles in nearly every facet of brain development and function; abnormalities 
in glia have important implications in neurological disorders and neurodegenerative 
diseases.  Despite considerable knowledge on the role of several ligand-receptor 
complexes that regulate astrocyte and oligodendrocyte specification, the 
transcriptional mechanisms critical for their development in the brain remain 
unknown.  The loss of astrocytes and oligodendrocytes is not due to cell death or 
increased neurogenesis.  SRF-deficient NPCs exhibited normal growth rate and 
capacity to self-renew but were deficient in glial specification in response to several 
pro-astrocytic or pro-oligodendrocyte signals in vitro.  Similarly, we observed an 
increase in the number of proliferative cells in the ventricular zone from embryonic 
day 14 to day 18, suggesting that SRF-deficient precursor cells accumulate as they 
fail to acquire post-mitotic glial cell-fates.  In contrast, conditional SRF deletion in 
developing forebrain neurons (Srf-NEX-cKO) did not affect astrocyte 
differentiation, suggesting a cell-autonomous role for SRF in astrocyte specification.  
Mechanistically, SRF mediates astrocyte fate-choice by regulating Notch2 receptor 
expression in NPCs, and Notch2 receptor deletion in NPCs phenocopies the deficits 
in astrocyte specification.  Interestingly, conditional SRF deletion in committed 
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astrocytes (Srf-GFAP-cKO) exhibited hypertrophic and gliosis morphology 
concomitant with a 4-6 fold increase in astrocytes throughout the brain of 4-week 
old mutant mice.  Together, our findings show that SRF is required, but not 
sufficient, for astrocyte and oligodendrocyte specification in the brain; SRF is 
necessary in a cell-autonomous manner in NPCs to regulate astrocyte specification 
and it plays a critical role in committed astrocytes for proper development. 
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Introduction 
Chapter 1: Introduction 
Central nervous system development 
The development of mammalian central nervous system requires a precise 
orchestration of temporally and regionally specific molecular events within the 
population of neural stem/precursor cells (NPC) to establish a highly organized 
and sophisticated organ comprised of three predominant cell types—neuron, 
astrocyte and oligodendrocyte. These molecular events are initiated and 
modulated sequentially by inductive extracellular cues and intracellular signaling 
pathways, which lead to the generation of neurons, followed by astrocytes, then 
oligodendrocytes in the developing cortex. In rodents, neurogenesis begins at 
embryonic day (E)12, peaks at E14, and gradually recedes around E17. Astrocyte 
specification begins at E18, peaks around P0 to P2, and is followed by 
oligodendrocyte formation which is first seen postnatally with peak production at 
P14 (Levison et al., 1993; Zerlin et al., 1995; Parnavelas, 1999). 
 
 Neurogenesis 
 In the mammalian cortex, the earliest proliferating NPCs constitute a 
single layer of pseudostratified columnar epithelium, also called the 
neuroepithelial cells (Gotz and Huttner, 2005).  These NPCs can undergo  
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symmetric divisions, giving rise to two proliferative precursor daughter cells, or 
an asymmetric a cell division, generating a daughter cell with the same precursor 
fate as well as one with restricted lineage commitment such as a neuron 
(McConnell, 1995; Rakic, 1995).  During early neurogenic phase, the initial 
population of neurons establishes the preplate first, then they populate the cortical 
plate in an inside-out fashion, and cortical neurogenesis is mostly complete during 
the embryonic period (Okano and Temple, 2009a). Radial glia, a population of 
proliferative cells that arise from the neuroepithelium after the onset of 
neurogenesis, are a pivotal source of neurons and provide scaffold support for 
cortical layering establishment (Kriegstein and Gotz, 2003; Anthony et al., 2004; 
Merkle et al., 2004; Englund et al., 2005).  Initially, radial glial cells that reside in 
the ventricular zone undergo asymmetric cell division to give rise to lower level 
cortical pyramidal neurons; radial glia also undergo symmetrical cell division that 
takes place primarily at the basal level of the ventricular zone to generate 
intermediate progenitor cells, which are restricted to the neuronal fate, that then 
give rise to neurons populating the upper layer of the neocortex (Haubensak et al., 
2004; Noctor et al., 2004; Englund et al., 2005). Genetic analysis in Drosophila 
first identified a number of “pro-neural genes” that are transcription factors from 
the basic helix-loop-helix (bHLH) class and were demonstrated to be intrinsic 
determinants that are necessary and sufficient to promote the commitment of 
precursor cells to neuronal lineage (Bertrand et al., 2002).  
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These pro-neural genes were found to be expressed primarily, if not exclusively, 
in the developing nervous system in vertebrates. For example, neurogenin 1 and 2 
(Ngn1/2) are expressed in the ventricular zone only during neurogenesis 
(Gradwohl et al., 1996), and they function through binding onto E box domains to 
activate genes that promote neuronal cell-fate specification, and expression of 
Notch ligands — Delta and Jagged — that repress neuronal commitment in 
neighboring precursor cells (Fode et al., 1998; Sun et al., 2001). Furthermore, 
Ngn1 is capable of inhibiting glial cell-fate by sequestering CREB binding protein 
(CBP)/p300 from signal transducers and activators of transcription (STAT), 
which is a transcription factor crucial for gliogenesis (Sun et al., 2001). Another 
bHLH transcription factor Mash1, expressed in the olfactory epithelium, is 
required for olfactory neuron differentiation, and ablation of this gene results 
severe reduction of olfactory neurons (Cau et al., 1997). Importantly, inactivation 
of transcription factors that modulate neurogenesis such as Tbr2/Eomes can lead 
to anatomical disorders such as microcephaly and cognitive deficits (Baala et al., 
2007; Arnold et al., 2008).  
In early neurogenesis period, environmental signals such as bone 
morphogenic proteins (BMP) enhance neuronal specification by signaling through 
their heterotrimeric serine/threonine kinase receptors and activate downstream 
Smad transcription factors, allowing complex formation with CBP/p300, at a 
distinct site to which Ngn1 binds and resulting activation of neuronal genes 
expression (Li et al., 1998). Similarly, growth factors like neurotrophins and  
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platelet-derived growth factor (PDGF) couple with receptor tyrosine kinase (RTK) 
receptors, mediating the activation of SHP2-MEK-ERK Rsk signaling cascade. 
This promotes neurogenesis by phosphorylating C/EBP family of transcription 
factors that bind and transactivate neuron-specific genes, such as βIII-tubulin and 
math1, directly (Menard et al., 2002; Uittenbogaard et al., 2007). 
Other mechanisms that instruct neurogenesis act in part by ensuring 
gliogenesis is repressed during the neurogenic phase.  Like the Ngn1 
sequestration of CBP/p300 from STAT, neuregulin-1 inhibits glial cell-fate by 
binding to ErB4 receptors, leading to intracellular signaling and translocation of 
N-CoR, a corepressor for multiple transcription factors by complexing with 
histone deacetylases, from cytoplasm to the nucleus. This inhibits cytokine-
mediated gliogenesis by complex formation with the Notch effector 
recombination signal binding protein-Jκ (RBP-Jκ) and repress astrocytic genes 
such as gfap and s100β (Sardi et al., 2006). 
 
 Astrogenesis 
The switch from neurogenesis to gliogenesis, starting with astrocyte 
formation, has been found to be dependent on both intrinsic competency of the 
precursor cells and their extrinsic environment.  Culture experiments of early 
forebrain neural precursors have shown that they only generate neurons in the first 
few days and then astrocytes and oligodendrocytes – a reflection of intrinsic  
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programming.  Similarly, cells isolated from early embryonic cerebral cortex 
differentiate preferentially into neurons, whereas cells from late prenatal or early 
postnatal stages differentiate into astrocytes and oligodendrocytes (Qian et al., 
2000), suggesting their intrinsic cell-fate competency changes over-time. On the 
other hand, early embryonic precursor cells cultured with embryonic cortical 
slices differentiate into neurons, yet when cultured with postnatal cortical slices 
they adopt glial phenotype (Morrow et al., 2001), a result that demonstrates that 
the surrounding extracellular cues also play an important role. 
Accordingly, growth factors in the subfamily of interleukin 6 (IL6) cytokines, 
including ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), 
and cardiotrophin-1 (CT-1) have been shown to be particularly potent instructors 
of astrogenesis via the Janus kinase-signal transducers and activators of 
transcription (JAK-STAT) pathway.  Their interaction with LIFRβ and gp130 
receptors activates intracellular JAKs, which phosphorylate STAT transcription 
factors, allowing their association with CBP/p300 to specifically transactivate the 
expression of a subset of astrocytic genes, like gfap and s100β (Johe et al., 1996; 
Bonni et al., 1997; Rajan and McKay, 1998; Nakashima et al., 1999; Barnabe-
Heider et al., 2005).  The neurotrophic cytokine CT-1, for example, demonstrates 
a mechanism whereby new born cortical neurons can regulate the onset of 
astrocyte differentiation of neighboring precursor cells through the secretion CT-1 
as ligands of gp130 receptors.   
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The ablation of this neuron-derived factor causes perturbation of CBP/p300 
resulting 50-70 % reduction of cortical astrocytes in vivo, while enhanced 
expression via in utero electroporation leads to precocious gliogenesis (Barnabe-
Heider et al., 2005).  
Signaling of BMP2/4 collaboratively promotes astrogenesis with JAK-STAT 
pathway during gliogenic period through binding with CBP/p300.  Activation of 
BMP receptors phosphorylates Smad transcription factors, which then translocate 
to the nucleus forming a transcriptional complex with STAT3 and CBP/p300 to 
promote the transcription of astrocyte specific genes (Nakashima et al., 1999).  
BMP’s positive effect on astrogenesis is reinforced further by the induction of 
inhibitor of DNA binding (Id)1 and Id3 that sequester bHLH Ngn1 and Mash1 
from neuronal-specific promoters (Nakashima et al., 2001). 
Likewise, Notch signaling also enables astrocyte differentiation through 
direct transcriptional modulation of astrocytic genes.  Activation of Notch leads to 
the release of Notch intracellular domain (NICD), permitting its interaction with 
RBP-Jκ in the nucleus to promote the expression of proglial genes such as 
Hairy/enhancer of split (hes) and hes-related proteins (Hesr) that also act as 
inhibitors of pro-neuronal bHLHs (Louvi and Artavanis-Tsakonas, 2006). This 
gliogenesis role of Notch has been described widely from the peripheral nervous 
system (Morrison et al., 2000), the retina (Furukawa et al., 2000), to the neural 
precursors residing in the embryonic forebrain (Chambers et al., 2001) and adult  
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hippocampus (Tanigaki et al., 2001).  Recently, a novel regulatory action of 
Notch has been discovered.  In the embryo prior to the gliogenesis period, the 
methylation of astrocytic genes by methyl-CpG-binding protein 2 (MeCP2) 
results an inactive chromatin conformation that blocks the binding of STAT 
transcription factors (Takizawa et al., 2001b), a epigenetic form of control that 
inhibits the early precursor cell’s responsiveness to cytokine-mediated JAK-
STAT signaling.  In a study by Namihira et. al., they showed Notch signaling, 
activated by neighboring neuronal precursors, is required for the demethylation of 
astrocytic genes via upregulation of nuclear factor-1A (NF1A), a pro-astrocytic 
transcription factor, that binds to the promoters of astrocyte specific genes to 
block methylation exerted by DNA methyltransferase I (DNMT1) (Namihira et al., 
2009).  This finding demonstrates Notch signaling complements cytokine-
mediated JAK-STAT signaling to timely initiate astrocyte production and 
illustrates a concerted result involving both extrinsic cues and cell-intrinsic 
mechanisms. 
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Notch signaling cooperates with canonical JAK-STAT signaling to initiate the 
switch of neurogenesis to astrogenesis (Chenn, 2009).  
 
Transcription factor regulators of astrocyte differentiation  
Despite numerous insightful studies on the extracellular instructive cues that 
promote astrocyte differentiation beginning to emerge more than a decade ago, 
the intracellular transcriptional programs that specify astrocytic fate-choice still 
remain elusive.  The study conducted by Deneen et al., is one of the first to 
identify a family of transcription factors, NFIA and NFIB, as both necessary and 
sufficient for glial-fate specification.   
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These transcription factors antagonize neurogenesis and promote pro-gliogenic 
genetic programs in the ventricular zone of the spinal cord (Deneen et al., 2006).  
They demonstrated that this function of NFIA is mediated through the 
requirement of NFIA for the expression of Notch effector Hes5.  Interestingly, in 
the absence of NFIA, Notch effectors alone could not promote glial-fate 
commitment.  Another study by Stolt et al., demonstrated that Nestin-Cre driven 
conditional ablation of Sox9 transcription factor within neural stem cells in the 
spinal cord leads to defects in astrocyte and oligodendrocyte generation (Stolt et 
al., 2003).  Although the precise mechanism by which Sox9 coordinates the 
switch from neurogenesis to gliogenesis remains to be determined, their finding 
revealed an additional transcriptional network that is a crucial component of 
gliogenesis specification.  Furthermore, stem cell leukemia (Scl), a bHLH 
transcription factor, was shown in the mouse and chick embryonic spinal cord to 
be both necessary and sufficient for the acquisition of astrocyte cell-fate, by 
antagonizing Olig2-dependent generation of oligodendrocyte precursor cells 
(Muroyama et al., 2005).  Recognizing the need to have a more comprehensive 
understanding of the transcriptional programs that direct astrocyte specification, a 
recent study conducted a genome wide screen in silico using the Mahoney 
pictorial atlas to identify potential transcription factors that modulate astrocyte 
differentiation based on their spatial and temporal expression patterns.  This study 
identified Klf15 to be sufficient, but not necessary, for the genesis of precocious 
GFAP-positive astrocytes (Fu et al., 2009).   
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These advances are certainly valuable for a better understanding the genetic 
programs governing astrogenesis, or more broadly gliogenesis, but it remains to 
be established that whether these transcriptional regulators identified in the spinal 
cord are also equally essential for the same processes in different regions of the 
brain. 
Astrocytes are developmentally and functionally crucial for numerous 
aspects, including synaptogenesis, synaptic plasticity, modulating breathing 
rhythm generation, controlling blood flow as a part of the blood brain barrier, 
internalizing and clearing Aβ deposits, responding to brain injuries and enhance 
neuronal survival through reactive gliosis, and mediating Aβ-induced 
neurotoxicity via releasing pro-inflammatory cytokines (Freeman; Barres, 2008; 
Gourine et al., 2010).  Despite being the most abundant cell type within the rodent 
and human brain (Allen and Barres, 2009), astrocytes are the least well 
understood developmentally and molecularly. 
   
 Oligodendrocyte differentiation 
Oligodendrocyte specification occurs the latest, among the 3 predominant 
cell-types generated within the brain, at late embryonic and early postnatal 
periods from precursor cells of ventricular zones of the forebrain and the spinal 
cord (Miller, 1996; Lee et al., 2000).  Because oligogenesis is restricted regionally 
within the brain, various local environmental cues are critical for oligodendrocyte  
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development.  Extrinsic growth factors, such as neurtrophin-3 (NT-3) and platelet 
derived growth factor (PDGF), are important for promoting the proliferation of 
oligodendrocyte precursor cells (OPC) (Barres et al., 1994; Robinson and Miller, 
1996).  Extracellular sonic hedgehog (Shh) signal in ventral telencephalon was 
found to be necessary and sufficient for inducing commitment to oligodendrocyte 
precursor in both regions (Alberta et al., 2001; Tekki-Kessaris et al., 2001).  
Downstream to Shh signaling, two bHLH factors, Olig1 and Olig2, are of 
particular importance in oligodendrocyte development. Their ectopic expression 
demonstrated sufficiency to promote oligodendrocyte specification (Lu et al., 
2001; Zhou et al., 2001), while loss-of-function studies showed that in absence of 
Olig1/2 motor neurons and oligodendrocytes are largely abolished and precursor 
cells resort to interneuron and astrocyte lineages instead (Lu et al., 2002; Zhou 
and Anderson, 2002).  Interestingly, subsequent studies indicate that Olig bHLH 
factors not only promote oligodendrocytic lineage, but they also repress 
astrogenesis pathways by sequestering CBP/p300 from STAT3 (Fukuda et al., 
2004) and antagonize NF1 (Deneen et al., 2006). 
Besides positive bHLH factors, the transition to oligodendrocyte 
specification is also regulated intrinsically by repressive HLH Id proteins that 
through heterodimerization blocks the bHLH factors thereby inhibiting their 
transactivation of oligodendrocyte-related genes.  To permit oligodendrocyte 
differentiation, Id2 is translocated out of the nucleus to cytoplasm prior to the 
onset differentiation; overexpression of Id2 confirms suppression of  
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oligodendrocyte generation, while ablation of Id2 results precocious 
oligodendrocyte differentiation (Wang et al., 2001). 
In addition to transcriptional modulation, a recent study report an epigenetic 
regulation of oligodendrocyte lineage commitment and progression by histone 
deacetylases, HDAC1 and HDAC2, via interaction with Wnt signaling to increase 
the chromatin compaction and limit the accessibility of oligodendrocyte repressor 
genes, such as Id2 (Ye et al., 2009). 
Oligodendrocytes are functionally indispensable for higher organism nervous 
system as they are responsible for the generation and maintenance of myelin that 
facilitates neuronal salutatory transmission as well as for providing trophic 
support – for example, insulin growth factor-1 (IGF-1) and glial cell line-derived 
neurotrophic factor (GDNF) – to promote the survival of neurons and growth of 
axons (Wilkins et al., 2001; Wilkins et al., 2003).  Disruptions to oligodendrocyte 
development or health contributes to disorders such as multiple sclerosis and 
leukodystrophies (Baumann and Pham-Dinh, 2001). 
 
 CNS development dysregulation and disease 
In the past decade numerous studies have elucidated the intricate regulatory 
networks encompassing extracellular signaling cues and intrinsic molecular 
mechanisms that direct the formation of neurons, astrocytes, and oligodendrocytes.  
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However, our knowledge in these fields remains incomplete to fully unravel 
the fundamental perturbations within many neurodevelopmental disorders. For 
example, Noonan syndrome is a genetic disorder with a frequency of 1 in 2500 
births, involving missense mutations in the human ptpn11 (shp-2) gene and 
resulting learning disabilities and mental retardation in afflicted individuals 
(Noonan, 1994).  A recent study reported increased astrogenesis at the expense of 
neurogenesis in the mouse model of mutant SHP-2, which is a tyrosine 
phosphatase that when mutated in the germline leads to LEOPARD syndrome and 
mental retardations (Gauthier et al., 2007).  Further research in the direction of the 
regulation of cortical cell-fate decisions implicating SHP-2-related pathways and 
its broader functional implications may provide more insight to the biological 
dysregulation that lead to mental retardation in human patients.  Similarly, 
mutations that create loss-of-function in one allele of CBP/p300, a key integrator 
of signaling pathways of both neurogenesis and gliogenesis, is associated with 
cognitive impairments and mental retardation in Rubinstein-Taybi syndrome 
(Josselyn, 2005). Future studies in CBP/p300-related mechanisms of cell type 
specification may help us better understand the molecular and cellular processes 
that underlie cognitive dysfunction. 
Our overarching goal of studying CNS development is to better understand 
the molecular mechanisms that guide not only fundamental brain development, 
but also neurological disorders that emerge at as a result of dysregulated cell-fate 
and neuronal development. 
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 Serum Response Factor 
 SRF is one of the first activity-dependent transcription factors to be 
characterized and was originally isolated based on its ability to activate the c-Fos 
gene (Treisman, 1987, 1995).  Comprised of 508 amino acids in mammals, SRF is 
a highly evolutionarily conserved MADS-domain containing transcription factor 
that binds as a homodimer to the serum response element (SRE) dyad symmetry 
sequence (CC(A/T)6GG), also referred to as a CArG domain (Treisman, 1987; 
Norman et al., 1988).  SRF has very little structural similarity to other mammalian 
proteins suggesting little or no functional redundancy with other factors.  This is 
illustrated by the early embryonic lethality (~E9.5) of SRF homozygous null mice 
due to its vital requirement for mesoderm formation, in a non-cell-autonomous 
manner (Arsenian et al., 1998; Weinhold et al., 2000).  However, because the 
animal body is capable for developing largely normally up to E6.5 from a 
blastocyst, SRF is thought to be dispensable for embryonic stem (ES) cell 
proliferation and cell cycle progression.  This was verified by a functional study 
of SRF-deficient ES cells that showed albeit SRF is required for the activation of 
immediate early genes (IEGs) – many of which are involved in the G0 – G1 cell 
cycle transition – SRF itself is dispensable for ES cells proliferation (Schratt et al., 
2001).  Furthermore, SRF was found to contribute to the regulation of apoptosis 
particularly during differentiation through direct targeting of the Bcl-2 expression, 
which is an anti-apoptotic gene (Schratt et al., 2004).  Besides its importance for 
the aforementioned developmental processes, SRF controls the cellular structural  
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organization via the expression of cytoskeletal structures – such as F-actin – and 
focal adhesion components – including vinculin and β1-integrin (Schratt et al., 
2002).  
 
Protein structure of SRF and nucleotide sequences of the CArG element, also 
known as a SRE site (Niu et al., 2007). 
  
Interestingly, SRF deletion in post-natal brain did not affect neuronal cell 
survival or cellular architecture in vivo and the adult mouse brain lacking SRF 
exhibit specific defects in activity-induced expression of several neuronal 
plasticity genes (Ramanan et al., 2005; Etkin et al., 2006).  While basal synaptic 
transmission does not require SRF, it is a gene of important function in regulating 
both LTP and LTD and its absence restricted to forebrain mature neurons caused  
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learning and memory behavioral deficits (Ramanan et al., 2005; Etkin et al., 2006).  
SRF is activated by several physiological stimuli including growth 
factors/mitogens, glucose, serum, and neuronal activity; its activation of target 
genes such as IEGs and cytoskeletal genes is facilitated by a ternary complex 
transcription factor (TCF) (Treisman, 1994; Whitmarsh et al., 1995; Liao et al., 
1997).  The ternary complex consists of the SRF homodimer and an Ets-domain 
family transcription factor, the best characterized of which is p62Elk1 (Elk1).  
Extracellular stimuli that result in SRE-mediated transcription promote both TCF-
dependent and TCF-independent transcription.  In the TCF-dependent mechanism, 
activated intracellular signaling through the MAPK cascades result in the 
phosphorylation of multiple serine and threonine residues on Elk1.  These 
phosphorylation events are necessary for the TCF-dependent SRE-mediated 
transcription (Hill et al., 1993; Marais et al., 1993). 
 
Functions of SRF in CNS development   
Until recently, SRF function has been exclusively studied in the ES cell in 
vitro system and in vivo in the cardiac system, where SRF has been shown to play 
a critical role in orchestrating smooth and cardiac muscle differentiation (Miano, 
2003; McDonald et al., 2006; Ivey et al., 2008; Niu et al., 2008).  While earlier 
studies using cultured neurons demonstrated the importance of SRF for stimulus-
dependent transcription, very little was known about its in vivo functions in the  
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brain and elsewhere owing to the early embryonic lethality of the Srf null mice 
(Arsenian et al., 1998).  To ascertain the role of SRF in neuronal development and 
plasticity, Srf conditional knockout mice were generated with SRF ablation 
restricted to postmitotic neuronal populations in the CNS.  Deletion of SRF at late 
prenatal stages in the forebrain leads to defects in neuronal rostral migratory 
stream (RMS) migration from subventricular zone (SVZ) to the olfactory bulb 
(Alberti et al., 2005).  The migration defects were attributed in part to alterations 
in actin cytoskeletal dynamics and particularly due to decreased levels of 
expressed and polymerized F-actin along with functional deficits in actin severing 
proteins, gelsolin and cofilin, in the SRF deficient neurons (Alberti et al., 2005).  
These mice also exhibited several phenotypic abnormalities such as poor feeding 
behavior, reduced size and weight and impaired locomotor activity and finally 
death by 3 weeks of age (Alberti et al., 2005).  Postnatal neuronal deletion of SRF 
yielded several interesting results: (a) SRF is critical for activity-dependent 
expression of several neuronal plasticity genes including c-Fos, Egr1, Egr2, and 
Arc; (b) unlike in ES cells, SRF deletion does not affect cell survival or cellular 
architecture in vivo, and (c) while basal synaptic transmission does not require 
SRF, it has an important role in regulating both long-term synaptic potentiation 
(LTP) and synaptic depression (LTD) (Ramanan et al., 2005; Etkin et al., 2006). 
Additionally, by analyzing conditional mutants in which SRF is ablated in 
mature neurons, a study revealed that it is necessary for hippocampal circuitry 
formation, mossy fiber segregation, and axonal guidance through ephrin-A and  
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semaphorin mediated signaling (Knoll et al., 2006).  These results confirmed 
SRF’s role as a master regulator of cytoskeletal machinery, actin dynamics, and 
lamellipodial and filopodial formation within the brain, as it is in many other cell 
types (Miano et al., 2007; Knoll and Nordheim, 2009).  In vitro studies of SRF-
deficient and inactive megakaryoblastic leukemia (MKL), a forebrain-enriched 
co-factor of SRF, hippocampal/cortical neurons further showed that SRF 
transcriptional activity is essential for neurite generation and outgrowth and 
dendritic complexity (Ishikawa et al.; Stern et al., 2009)  This function is 
promoted by activin, a member of the transforming growth factor β (TGF-β) 
superfamily, and repressed by suppressor of cancer cell invasion (SCAI) within 
the nucleus.  Although physiologically it is demonstrated that SRF modulates 
hippocampal dendritic development through reelin signaling (Stritt and Knoll), 
but concrete findings on which axonal tracts require SRF within the brain is still 
unknown.  This has not been shown in vivo because that many researchers do not 
yet have conditional mutant mice of SRF that delete the gene sufficiently early, 
prior to neuronal development.       
A recent study by Stritt et al., reported a novel function of SRF in modulating 
oligodendrocyte maturation as the authors found a reduction of mature 
oligodendrocytes and an increase in oligodendrocyte precursor cells when SRF is 
ablated specifically in neurons utilizing CaMKIIα-Cre mediated recombination.  
This paracrine regulation is shown to be a result of SRF’s function as a repressor 
of expression of connective tissue growth factor (CTGF) within neurons, a  
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factor that inhibits neighboring oligodendrocyte precursors to mature by 
suppressing the insulin-like growth factor (IGF-1) signaling (Stritt et al., 2009). 
 
Current field of knowledge of SRF’s functions in CNS cellular development and 
functioning (Knoll and Nordheim, 2009). 
  
Relating to neurological disorders of CNS, studies have found a link between 
SRF and Alzheimer’s disease pathology as SRF is expressed at high levels within 
the vascular smooth muscle cells (VSMC) – both in patients and in mouse  
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models – governing cerebral blood flow and LRP-mediated amyloid β clearance 
(Chow et al., 2007; Bell et al., 2009).  Conventionally, Alzheimer’s research 
focused primarily on the degeneration of neurons as the origin of pathogenesis.  
More recently, increasing evidence shows that cerebral blood flow regulation is 
also very important for neuronal homeostasis and synaptic transmission – 
perturbation of which contributes to cognitive decline – and physiological 
clearance of soluble amyloid β.  The aforementioned studies showed that the 
knockdown of SRF activity using short-hairpin RNAs normalized the contractility 
of SMCs and improved the hypoperfusion phenotype in animal models.  Higher 
SRF activity was found to reduce amyloid β clearance through enhancing the 
expression of SREBP2, which is a repressor of the LRP1 receptor that modulates 
amyloid β clearance (Chow et al., 2007; Bell et al., 2009).  These results are 
promising as they suggest further understanding of SRF function and 
appropriately managing its activity in cerebral vasculatures could be a therapeutic 
target to help Alzheimer’s patients, for whom there currently are no effective 
treatments to slow their cognitive deterioration and disease progression.  
 
 Brain development, SRF, and what is missing?   
Because existing knowledge of the functional roles of SRF within the brain 
were mostly derived from postnatal neuronal conditional mutant studies and in 
vitro neuronal culture studies, it is unknown whether SRF – as a highly brain- 
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enriched and a unique stimulus-dependent transcription factor – plays a role in 
regulating brain development.  Specifically, is SRF required for cell-fate 
specifications that govern neurogenesis, astrogenesis, and oligodendrocyte 
differentiation?  Lack of SRF undermines neurite outgrowth in culture, but is SRF 
necessary for neuronal innervations in vivo or could this effect be compensated by 
the much more complex environment within the brain?  If so, which major tracts 
and axonal projections require SRF for establishment?  Does SRF function 
similarly in NPCs as it does in ES cells?  As a stimulus-dependent transcription 
factor, is SRF needed for the proliferation and self-renewal of NPCs?  Is SRF also 
needed for cell survival in NPCs just as it is for ES cells undergoing 
differentiation?   
To address these questions, we crossed our SRF conditional floxed mouse 
with a Nestin-Cre recombinase mouse in which Cre expression is driven by the 
Nestin promoter and is restricted to NPCs in the brain and spinal cord prior to 
cell-fate lineage commitment and the establishment of neuronal arborization.  
Moreover, utilizing different cell-type specific transgenic lines – including a 
neuronal-specific NEX-Cre line and an astrocyte-lineage specific GFAP-Cre 
line – as well as neurosphere culture techniques, we aim to define the cellular 
context of which SRF controls these processes and elucidate their underlying 
molecular mechanisms. 
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Chapter 2:  The Role of SRF in Neuronal Development 
This chapter was published in the Journal of Neuroscience on November 16, 2011. 
31(46): 16651- 16664 
Serum Response Factor Is Required for Cortical Axon Growth But Is 
Dispensable for Neurogenesis and Neocortical Lamination 
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Abstract 
Previous studies have shown that neuron-specific deletion of serum 
response factor (SRF) results in deficits in tangential cell migration, guidance-
dependent circuit assembly, activity-dependent gene expression, and synaptic 
plasticity in the hippocampus. Furthermore, SRF deletion in mouse embryonic 
stem cells causes cell death in vitro. However, the requirement of SRF for early 
neuronal development including neural stem cell homeostasis, neurogenesis, and 
axonal innervations remains unknown. Here, we report that SRF is critical for 
development of major axonal tracts in the forebrain. Conditional mutant mice 
lacking SRF in neural progenitor cells (Srf-Nestin-cKO) exhibit striking deficits 
in cortical axonal projections including corticostriatal, corticospinal, and 
corticothalamic tracts, and they show a variable loss of the corpus callosum. 
Neurogenesis and interneuron specification occur normally in the absence of SRF 
and the deficits in axonal projections were not due to a decrease or loss in cell 
numbers. Radial migration of neurons and neocortical lamination were also not 
affected. No aberrant cell death was observed during development, whereas there 
was an increase in the number of proliferative cells in the ventricular zone from 
embryonic day 14 to day 18. Similar axonal tract deficits were also observed in 
mutant mice lacking SRF in the developing excitatory neurons of neocortex and 
hippocampus (Srf-NEX-cKO). Together, these findings suggest distinct roles for 
SRF during neuronal development; SRF is specifically required in a cell- 
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autonomous manner for axonal tract development but is dispensable for cell 
survival, neurogenesis, neocortical lamination, and neuronal differentiation. 
 
Introduction 
Neuronal development in the CNS is an intricately coordinated process 
that involves proliferation and maintenance of neural precursor cells (NPCs), 
neurogenesis, growth and extension of axons and dendrites, and structural 
organization within specific brain regions. At the molecular level, these processes 
are regulated by several extracellular cues through activation of specific 
transcriptional programs (Goldberg et al., 2002; Zhou and Snider, 2006). Serum 
response factor (SRF) is a stimulus-dependent transcription factor belonging to 
the Mcm1-Agamous-Deficiens-SRF-domain family of transcriptional regulators. 
Thus far, the roles of SRF in CNS development remain poorly understood 
because of early embryonic lethality of SRF-null mice (Arsenian et al., 1998). 
Recent studies using conditional SRF mutant mice have begun to elucidate the 
importance of SRF in CNS development and adult function. Perinatal neuron-
specific deletion of SRF results in several developmental abnormalities, including 
defects in tangential neuronal migration along the rostral migratory stream, 
deficits in axon guidance within the hippocampal mossy fiber circuitry, 
hippocampal lamination and dendritic complexity of hippocampal pyramidal 
neurons, and ultimately resulting in lethality by 3 weeks of age (Alberti et al., 
2005; Kno¨ll et al., 2006; Stritt and Kno¨ll, 2010). In contrast, mice carrying  
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postnatal forebrain-specific deletion of SRF are viable and fertile, and do not 
exhibit any of the above developmental abnormalities (Ramanan et al., 2005; 
Etkin et al., 2006). Instead, these mice exhibit specific deficits in activity-
dependent expression of several immediate early genes (IEG), including c-Fos, 
Egr-1, and Arc, in the hippocampus and neocortex (Ramanan et al., 2005). SRF 
ablation does not affect basal synaptic transmission but disrupts both early and 
late phases of LTP and LTD in hippocampus and in cultured cerebellar Purkinje 
neurons (Ramanan et al., 2005; Etkin et al., 2006; Smith-Hicks et al., 2010). 
Interestingly, SRF loss does not affect neuronal cell survival and maintenance 
(Ramanan et al., 2005). Defects in activity-dependent transcription and synaptic 
plasticity are the likely underlying causes of learning and memory deficits 
observed in these mice (Etkin et al., 2006; Johnson et al., 2011). 
Despite these advances, the role of SRF in neural progenitor cell 
homeostasis, neurogenesis, and neuronal maturation during early brain 
development remains unknown. In this study, we conditionally deleted SRF in 
NPCs using a nestin-cre transgenic line to investigate earlier developmental roles 
of SRF. Srf-Nestin- cKO mutants exhibited neonatal lethality along with several 
abnormalities in brain architecture. Closer analysis revealed that loss of SRF 
affected the development of major CNS axonal fiber tracts. However, 
neurogenesis, neuronal subtype specification, and neuronal survival were 
unaffected. Similarly, Srf-NEX-cKO mutant mice, lacking SRF only in 
postmitotic glutamatergic neurons in the neocortex and hippocampus, also  
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exhibited defects in axonal projections suggesting a cell-autonomous role of SRF 
in axon growth in vivo. Contrary to previous findings, neocortical lamination 
occurs normally in both these lines of mutant mice. 
Last, examination of NPCs revealed an accumulation of precursors in Srf-
Nestin-cKO mutants suggesting that SRF plays an important role in NPC 
homeostasis. Thus, our study reveals a critical role for SRF in NPC maintenance 
and axon outgrowth during CNS development. 
 
Materials and Methods 
Animals. Srf f/f mice (control) were maintained as a homozygous colony 
as previously described (Ramanan et al., 2005). The Srf f/f were crossed to the 
nestin-Cre transgenic mouse strain (Tronche et al., 1999) (The Jackson 
Laboratory, Stock # 003771) to generate Srf f/_; Nestin-Cre double heterozygous 
mice. The double heterozygous mice were bred to Srf f/f mice to obtain Srf f/f; 
Nestin-Cre (Srf-Nestin-cKO) mutant mice in the expected Mendelian ratio. 
Similarly, Srf f/f mice were bred to the NEXcre transgenic mice to generate Srf f/f; 
NEX-Cre (Srf-NEX-cKO) mice (Goebbels et al., 2006). The Srf-NEX-cKO mice 
were viable and were bred to Srf f/f mice to propagate the colony. For 
experiments that required embryos of various developmental stages, we set up 
timed pregnancies with the day following detection of a vaginal plug being 
identified as embryonic day 0.5 (E0.5). All experiments were approved by the  
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Animals Studies Committee, Division of Comparative Medicine, Washington 
University School of Medicine, St. Louis, MO. 
Immunohistochemistry. Immunohistochemistry was performed as 
previously described (Ramanan et al., 2005). Briefly, postnatal day 0.5 (P0.5) and 
older animals were fixed by transcardial perfusion. The brains were cryopreserved 
in 30% sucrose, frozen, and stored at -80°C until use. For staining, 12–16 µm 
cryosections were made and incubated in blocking/permeabilization solution 
containing 3% normal goat serum and 0.3% Triton-X in PBS. Embryos until 
E18.5 were drop-fixed in 4% PFA followed by cryopreservation in 30% sucrose. 
The following primary antibodies were used: NeuN (1:1000, Millipore Bioscience 
Research Reagents), SRF (1:1500, Santa Cruz Biotechnology), 
2H3/Neurofilament (1:1000, DSHB), activated-Caspase 3 (1:1500, Millipore), 
Tbr2/EOMES (1:50, Santa Cruz Biotechnology), Tbr1 (1:250, Santa Cruz 
Biotechnology), Cux1 (1:5000, Santa Cruz Biotechnology), 40E-C/Vimentin 
(1:50, DSHB), somatostatin (SST; 1:600, Santa Cruz Biotechnology), calbindin 
(1:2000, Sigma-Aldrich), parvalbumin (1:1000, Sigma-Aldrich), Gad-6 (1:500, 
DHSB), p-histone H3 (1:500, Sigma-Aldrich), Ki67 (1:500, BD Biosciences), and 
Sox2 (1:100, Santa Cruz Biotechnology). 
The following secondary antibodies were used: anti-goat Cy3 (1:300, 
Jackson ImmunoResearch), anti-mouse Alexa Fluor 594 and Alexa Fluor 488 
(1:500, Invitrogen), and anti-rabbit Alexa Fluor 488 and Alexa Fluor 594 (1:500, 
Invitrogen). 
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TUNEL. Embryonic and neonatal brains were perfused with 4% PFA and 
cryoprotected in 30% sucrose. Samples were sectioned at 12–16µm. Before 
staining, sections were permeabilized with 0.1 M citrate buffer, pH 6.0, at 80°C 
for 30 min. Slides were rinsed with PBS and immersed in 0.1M Tris-HCl 
containing 3% BSA and 20% bovine serum for 30 min at room temperature. 
Finally, 50–100 _l of terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) reaction mixture (Roche) was added per slide and incubated at 
37°C in a humidified chamber in dark to complete the staining. 
In situ hybridization. In situ hybridization was performed as previously 
described (Ramanan et al., 2005). The cDNA clones of Cux2, Klf6, Lhx5, Lmo4, 
Nfix, Nr4a2, and Sox5 for riboprobes were generously provided by Paul Gray, 
Washington University School of Medicine, St. Louis, MO. Both sense and 
antisense riboprobes were synthesized and hybridized and sense strand probes did 
not produce any signal above that of the background. 
Cell counts. High-magnification (10x or 20x) images of 10 
nonconsecutive bregma axis-matched sections were taken using a Nikon 80i 
epifluorescence microscope. A universal threshold determined by signal to 
background ratio was applied to all images from control and knockout samples. 
Positive cells based on their nuclear staining were counted using Analyze Particle 
function with constraints on the particle size in pixels (300–2000 pixels) and 
circularity of the particle (0.4 –1.0) in ImageJ software. Total number of counts  
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per area in pixel square was computed and converted to counts per square 
micrometers based on the magnification of the image. 
DiI labeling. Tiny crystals of 1,1-dioctadecyl-3,3,3’,3’-
tetramethylindocarbocyanine perchlorate (DiI) similar in size were placed on the 
surface of the motor and the visual cortices (ipsilateral hemisphere) of neonatal 
Srf-Nestin-cKO, Srf-NEX-cKO, and control littermate brains, using an insect 
needle pin. Control and knock-out littermate brain pairs were positioned next to 
each other to ensure crystal placements were as comparable as possible. Samples 
were incubated in 37°C for 2–4 weeks and then sectioned coronally, sagittally, or 
horizontally at 100_mthickness using a vibratome. Sections were collected as 
floating sections and mounted serially on glass microscope slides using 
Vectashield mounting medium with DAPI (Vector Laboratories). For DiI staining 
of thalamocortical axons in sections, glass beads (250 µm, acid-washed, Supelco) 
were coated with DiI (2 mg of DiI in 100 ml of methylene chloride to coat 300 
mg of glass beads). A single DiI-coated bead was placed in the ventral thalamus 
of 100 µm paraformaldehyde-fixed coronal section and incubated for 3 weeks at 
37°C. 
Quantification of axonal projections. DiI-labeled corticostriatal 
projections in 2–3 slices were measured for projection length using ImageJ to 
track and record the absolute length in pixels and then converted to micrometers. 
For measuring the target innervation of corticothalamic projection, DiI-labeled 
thalamic area was measured using ImageJ in square pixels and then converted to  
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square micrometers. Mean of projection length or target innervation area of 
comparable sections from three pairs of control and mutant animals was 
calculated to quantify for the difference between control and mutants. 
Nissl staining. Fresh frozen brains were sectioned at 20 µm and mounted 
on gelatin-coated glass slides. After overnight drying, slides were immersed in 
0.5% cresyl violet in water for 10 min; rinsed in H2O; dehydrated serially in 50%, 
75%, 95%, and 100% ethanol (2 min each), followed by two rinses in xylenes (3 
min each); and then coverglass mounted with permount histology mounting 
medium. 
Statistical analyses. The mean, SD and SEM for cell counts were 
calculated from images, which were sampled serially to encompass a structural 
region. Pups of either sex (n = 3–5) from at least two different litters were used in 
all experiments. Statistical significance between control and mutant pair was 
determined by Student’s t test. 
 
Results 
Ablation of SRF in Srf-Nestin-cKO mutant brain 
To determine the role of SRF in neurogenesis and CNS development, we 
deleted SRF using a nestin-Cre transgenic mouse line, in which Cre-mediated 
recombination has been shown to occur ~E9.5 to E11.5 (Tronche et al., 1999). 
Srf-Nestin-cKO animals were born in the expected Mendelian ratio, but the 
mutant mice did not survive beyond P1 due to unknown reasons.  
31 
 
Chapter 2: SRF in neurons 
The Srf-Nestin-cKO mice were physically indistinguishable from control 
littermates (Srf f/f) but exhibited neonatal hemorrhage starting ~12–16 h after 
birth (Fig. 1A). In the Srf-Nestin-cKO mutant mice, SRF deletion begins_E12.5 
and is complete by E14.5 in the brain and spinal cord as determined by 
immunohistochemistry (data not shown). SRF loss was also confirmed by 
immunoblotting using whole brain lysates from neonatal control and Srf-Nestin-
cKO mice (Fig. 1B). A closer examination of spatial deletion of SRF at P0.5 in 
Srf-Nestin-cKO brains by immunostaining using anti-SRF antibody demonstrates 
loss of SRF in all regions examined, including the neocortex, hippocampus, 
striatum, thalamus, and hypothalamus (Fig. 1C, data not shown).  
Coimmunostaining for NeuN, a marker of mature neurons, and SRF showed 
absence of SRF expression in neurons throughout the brain (Fig. 1D, data not 
shown). 
To analyze the consequence of SRF ablation on brain morphology, we 
performed nissl staining of P0.5 Srf-Nestin-cKO and control brains. The mutant 
mice exhibited enlarged lateral ventricles and the corpus callosum was present 
only in the most rostral part of the brain (Fig. 1E). In the Srf--Nestin-cKO mutant 
brain, several of the white matter tracts were notably absent or greatly diminished 
compared with control mice. In the rostral forebrain, the anterior commissure was 
absent and the lateral ventricular zones were also enlarged in Srf-Nestin-cKO 
mice (Fig. 1E). More caudally, the stria medullaris, mammilothalamic tract, 
internal capsule, and anterior commissure were also markedly diminished in  
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Srf-Nestin-cKO mice compared with those in control littermates (Fig. 1E). The 
hippocampus was smaller and the dentate gyrus was more compact while the CA1 
pyramidal cell layer was disorganized (Fig. 1F). 
 
 
Figure 1. SRF deletion in Srf-Nestin-cKO mutants. A, Srf-Nestin-cKO mice 
exhibited neonatal hemorrhage starting 12–16 h after birth while the brains of  
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control littermates were normal. The mutant mice died by 18 –24 h. The weight of 
the brains was comparable. B, Immunoblotting using whole brain lysates shows 
complete loss of SRF in P0.5 Srf-Nestin-cKO mice. C, Immunostaining using a 
SRF-specific antibody shows loss of SRF expression in forebrain regions 
including the neocortex, striatum, and hippocampus. Scale bars: Neocortex, 50μm; 
others, 150μm. D, Co-immunofluorescence staining for SRF and the neuron-
specific marker, NeuN, shows deletion of SRF in neurons of Srf-Nestin-cKO mice 
compared with control littermates. Scale bar, 30μm. E, Forebrain nissl staining 
reveals several abnormalities in the mutant brains. Compared with control 
littermates, Srf-Nestin-cKO mice exhibit enlarged lateral ventricles (asterisk) and 
greatly diminished anterior commissure (a.c), stria medullaris (str.), 
mammilothalamic tract (m.t), and internal capsule (i.c). F, Closer examination of 
the mutant hippocampus shows that the dentate gyrus is more compact (arrow) 
and cellular lamination of CA3 and CA1 fields are more aberrant (arrowheads) 
than those of control littermates. Asterisk indicates enlarged lateral ventricle in 
the caudal forebrain. Scale bar, 150μm. 
 
SRF is required for proper establishment of cortical axonal innervations 
Given these deficits in white matter tracts, we further analyzed axon 
growth in Srf-Nestin-cKO mice. Immunostaining using anti-neurofilament 
antibody (anti-2H3) revealed striking loss of entorhinal-hippocampal or perforant 
path innervations in the hippocampus of Srf-Nestin-cKO mutants  
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(Fig. 2A, n = 3 animals). The entorhinal-hippocampal pathway, which is 
important for hippocampal plasticity (Bliss and Gardner-Medwin, 1973), is 
comprised of the axonal projections primarily from the entorhinal cortex layer 
II/III neurons that innervate all fields of CA1 pyramidal neurons, granular neurons 
of the dentate gyrus, and subicular neurons in the hippocampus (Witter et al., 
2000). Furthermore, we found a substantial reduction in corticostriatal 
innervations, which arise mainly from layer V cortical pyramidal neurons in the 
Srf-Nestin-cKO mutants compared with control littermates (Fig. 2B, n= 3 
animals). As observed with nissl staining, anti-2H3 staining also revealed a lack 
of or deficits in anterior commissure, fasciculus retroflexis, and internal capsule in 
Srf-Nestin-cKO mice compared with control mice (Fig. 2C, n = 3 mice). We also 
performed anti-β-III tubulin (anti-Tuj1) immunostaining of sagittal brain sections 
to visualize the corticospinal tract projections of pyramidal neurons in layer V of 
the motor cortex. We observed significantly less abundant corticospinal 
projections through the internal capsule and cerebral peduncle in the Srf-Nestin-
cKO brains as compared with control littermates (data not shown). 
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Figure 2. Srf-Nestin-cKO mutant mice exhibit axonal growth deficits. A, 
Neurofilament immunostaining using anti-2H3 antibody reveals absence of 
entorhinal-hippocampal innervation in the hippocampus of Srf-Nestin-cKO mice. 
Inset shows the magnified view of the region indicated by the arrow. B, 
Examination of neurofilament expression in striatum shows less abundant  
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corticostriatal projections in Srf-Nestin-cKO brains than in control littermates, n = 
3 mice. Right, Magnified views of the boxed regions in B, showing sparse axonal 
projections in the Srf-Nestin-cKO mice compared with control littermates. C, 
Anti-2H3 neurofilament staining shows absence or highly reduced anterior 
commissure (arrows), fasciculus retroflexis (arrows), and internal capsule. 
Enlarged view of the boxed region is shown for each fiber tract. Scale bars: A and 
C, large panels, and B, left, 500μm; A, insets, and B, right, 100μm. DG, Dentate 
gyrus; Ctx, neocortex; Str, striatum; Hip, hippocampus. 
 
 
In addition to immunostaining, we used DiI labeling to visualize axonal 
projections in vivo. DiI crystals were placed on the surface of the brain 
corresponding to the motor and visual cortices of one hemisphere (Fig. 3A). To 
ensure the comparisons between control and mutant brain sections are made 
accurately, we cross-examined all coronal serial sections from the anterior to the 
posterior forebrain. As observed for anti-neurofilament immunostaining (anti-
2H3), DiI labeling showed significant deficits in the corticostriatal projections in 
Srf-Nestin-cKO brains. In the anterior forebrain region of control mice, the 
projections from the cortical neurons clearly innervated the striatum. However, in 
Srf-Nestin-cKO brains these projections mostly terminate in the lateral corpus 
callosum and fail to reach their targets in the striatum (Fig. 3B,D; projection 
length: control, 460 ± 13 µm; Srf-Nestin-cKO, 248± 55µm; n= 2 mice; p < 0.05).  
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In the posterior forebrain of control mice, we observed robust corticothalamic 
projections innervating the thalamus. Strikingly, these corticothalamic 
innervations were absent in Srf-Nestin-cKO brain (Fig. 3C,D; projection area: 
control, 20,875 ± 1127 µm2; Srf-Nestin-cKO, 1619 ± 2894 µm2; p < 0.01). 
Furthermore, we also observed lack of innervations to the dorsal hippocampal 
commissure in the Srf-Nestin-cKO mice (Fig. 3C). DiI labeling further confirmed 
the deficits in anterior commissure and corpus callosum observed using anti-2H3 
immunostaining (Fig.3 E,F). We then asked whether projections to the cortex 
were also affected in the mutant mice. DiI-coated beads placed in the ventral 
thalamus revealed striking deficits in thalamocortical projections in Srf-Nestin-
cKO mutant mice compared with control (Fig. 3G, n = 2 mice). The axonal 
projection deficits in the Srf-Nestin-cKO mutant mice were consistent in all 
animals analyzed. Together, these observations suggest that SRF plays a critical 
role in the formation of axonal tracts during neural development. 
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Figure 3. Corticostriatal, corticothalamic, and thalamocortical projections are 
impaired in Srf-Nestin-cKO mice. A, DiI-labeled P0.5 brain showing the position 
of the DiI crystals. DiI crystals were placed on the surface of the brain in motor  
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and visual cortices of control and Srf-Nestin-cKO mice. B, Coronal section of the 
anterior forebrain shows robust corticostriatal projection (arrows) into the 
striatum in the control, but not in Srf-Nestin-cKO brain. Instead, innervations 
mostly terminate in the corpus callosum in Srf-Nestin-cKO mice. C, Examination 
of the posterior forebrain reveals a striking absence of corticothalamic projection 
(arrows) and lack of innervation into the dorsal hippocampal commissure 
(arrowhead) in the mutant brain. D, Quantification of axon length from the 
position of the DiI crystal in the anterior region (B) and the area of target 
innervation in the posterior region (C) of the brain are shown (n = 3 mice). E, F, 
DiI labeling shows absence of anterior commissure (E) and corpus callosum (F) 
inSrf-Nestin-cKO mice compared with control littermates. Scale bar, 200μm.G, 
DiI labeling from the thalamus reveals deficits in thalamocortical projections in 
Srf-Nestin-cKO mutant mice while robust projections are seen in control 
littermates. Asterisk indicates position of the DiI-coated bead. Scale bar, 100μm. 
 
Defects in neuronal projections are not a result of cell death or defects in 
neurogenesis 
The deficits in axonal projections could result from a requirement of SRF 
for axon growth or from cell loss as a result of apoptosis. A previous study has 
shown that SRF is required for the survival of mouse embryonic stem cells and 
that SRF promotes cell survival by regulating the expression of the antiapoptotic 
gene, Bcl-2 (Schratt et al., 2004).  
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Also, SRF has been shown to promote survival of neocortical neurons under 
conditions of trophic deprivation in vitro (Chang et al., 2004). To determine 
whether deficits in axonal projections are due to cell loss during development, we 
first assessed cell death using TUNEL assay and immunostaining for activated-
caspase 3 expression at P0.5. We did not find any increase in the number of 
TUNELpositive and activated caspase-3-positive cells in the brains of Srf-Nestin-
cKO brains as compared with control littermates (Fig. 4A). To ascertain whether 
increased cell death could have occurred earlier during brain development, we 
analyzed the brains of control and Srf-Nestin-cKO mice at E14.5, E16.5, and 
E18.5. We did not observe any difference in cell death at any of these stages 
between Srf-Nestin-cKO and control littermates, suggesting that SRF-deletion 
does not cause apoptotic cell death during brain development (Fig. 4B–D). 
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Figure 4. Loss of SRF does not cause apoptotic cell death during brain 
development. A, TUNEL cell death assay and immunostaining for cleaved 
activated-caspase3 (act-Casp3) show no detectable elevation of apoptotic cell 
death in vivo in the absence of SRF at birth. Scale bar, 100μm. B–D, Both 
TUNEL assay and immunostaining against activated-Caspase3 at E18.5, E16.5, 
and E14.5 indicate no significant elevation in the number of apoptotic cells in Srf-
Nestin-cKO neocortex. CP, Cortical plate; IZ, intermediate zone; SVZ, 
subventricular zone; VZ, ventricular zone. Scale bar, 100μm. 
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Although we did not see any increased cell death in the brains of Srf-
Nestin-cKO mice during development, it is possible that the deficits in axonal 
tract formation observed in these mutant mice could be due to deficits in the total 
number of neurons generated. To investigate the effect of SRF loss on 
neurogenesis, we determined the number of neurons in control and Srf-Nestin-
cKO brains by immunostaining for NeuN, a marker for mature neuronal cell 
nuclei. We found that the total number of NeuN positive cells was similar in both 
Srf-Nestin-cKO and control littermates (Fig. 5A–D; neocortex: control 100 ± 
4.5% and knock-out 108.95 ± 6.2%; striatum: control 100 ± 3.5% and knock-out 
105.2 ± 4.4%; thalamus: control 100 ± 6.0% and knock-out 106.1 ± 2.7%; 
hippocampus: control 100 ± 5.9% and knock-out 103.5 ± 8.0%; and dentate gyrus: 
control 100 ± 7.6% and knock-out 92.8 ± 3.1%. Data shown are mean ± SEM as a 
percentage of mean; n = 3 mice). Although the dentate gyrus in Srf-Nestin-cKO 
mice appeared smaller, it had a higher cell density than that of control animals 
and there were no appreciable differences in total neuronal numbers (Fig. 5C, data 
not shown).  
We also analyzed the number of intermediate neuronal precursors (INPs), 
as identified by Tbr2 (or Eomes) expression, and found no statistically significant 
difference in the total number of INPs within the neocortex of Srf-Nestin-cKO 
mice and control littermates (Fig. 5E; control 100 ± 6.5% and knock-out 96 ± 
5.8%; p < 0.001; n ± 3 mice). 
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Together, these results demonstrate that SRF is not required for cell 
survival and neurogenesis and that the deficits in axonal projections observed in 
Srf-Nestin-cKO brains reflect a specific requirement for SRF for axon growth. 
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Figure 5. Loss of SRF does not affect neurogenesis. A, Srf-Nestin-cKO mutants 
exhibit no significant changes in the number of neurons generated, as indicated by 
NeuN immunostaining, in the neocortex. ctx, Neocortex; c.c, corpus callosum. A’, 
Magnified view of boxed regions shown in A. B, C, Immunostaining for NeuN in 
the striatum and thalamus (B) and hippocampus (C) of control and Srf-Nestin-
cKO mice. Although the dentate gyrus is more compact in Srf-Nestin-cKO mice, 
there is no significant difference in the number of cells compared with control 
mice. Scale bars: A–C, 100 μm. D, Quantification of total number of NeuN-
positive cells in neocortex, striatum, thalamus, and hippocampus. Error bars 
represent SEM. Student’s t test analysis between control and Srf-Nestin-cKO 
animals shows no statistically significant differences. E, Immunostaining for Tbr2 
(or Eomes), a marker for intermediate neuronal progenitors, showed no difference 
in total number of committed neuronal precursors in Srf-Nestin-cKO mice and 
control littermates. Scale bar, 50μm. 
 
SRF is not required for projection neuron subtype specification and cortical 
lamination 
We next asked whether SRF was required for neuronal subtype 
specification. The excitatory projection neurons reside in defined layers of the 
neocortex and make intracortical, subcortical, or subcerebral connections 
(Molyneaux et al., 2007). A number of transcription factors, including Fezf2 and 
Ctip2, are critical for specification of cortical projection neuron subtypes and their  
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loss results in absence of subcerebral and subcortical projections (Arlotta et al., 
2005; Chen et al., 2005; Molyneaux et al., 2005; Chen et al., 2008). Therefore, it 
is possible that the lack of cortical projections observed in Srf-Nestin-cKO 
mutants could be attributed to a switch in projection neuron identity, a result that 
could affect neocortical lamination. To study this, we probed for expression of 
Tbr1, a deep-layer neuronal marker, and Cux1, which is specifically expressed in 
neocortical layers 2–4 (Hevner et al., 2001; Ferrere et al., 2006). Immunostaining 
of P0.5 brains revealed no differences in the layer-specific expression patterns of 
both Tbr1 and Cux1 in Srf-Nestin-cKO mice and control littermates (Fig. 6A,B). 
Additionally, we also probed for expression of other neocortical layer-specific 
transcription factors by in situ hybridization (Gray et al., 2004). Expression 
patterns of several transcription factors, including Cux2, Klf6, Lhx5, Lmo4, Nfix, 
Nr4a2, and Sox5, which specify the identity and position of projection neuron 
subtypes, were similar between Srf-Nestin-cKO mice and control littermates (Fig. 
6C, data not shown). These results indicate that there are no changes in the 
establishment of layer-specific neuronal subtypes and neocortical lamination at 
P0.5 in the brains of Srf-Nestin-cKO mice.  
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Figure 6. SRF is dispensable for neocortical lamination and projection neuron 
subtype specification. A, Immunostaining for Tbr1 expression, a marker of deep 
layer neurons in the neocortex, shows normal layer VI lamination in Srf-Nestin-
cKO and control brains. Shown here is the retrosplenial cortex. B, 
Immunofluorescence staining for expression of Tbr1 and Cux 1 (a marker for  
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superficial layer neurons) in the neocortex shows that both layer 2/3 and layer VI 
neurons are specified and positioned normally in knock-out mice. c.c., Corpus 
callosum. C, In situ hybridization of layer-specific transcription factors, including 
Lmo4, Cux2, and Lhx5, shows that neocortical lamination and the specification of 
those subtypes are normal in the absence of SRF. Arrows point to Cux2- or Lhx5-
expressing upper layer neurons. Scale bars: A, C, 200μm; B, 100μm. D, 
Immunostaining using anti-vimentin antibody, expressed in radial glial processes, 
show that the structural integrity of radial glia is normal in Srf-Nestin-cKO brain. 
E, Magnified images of boxed regions in D show normal appearance of radial 
glial processes in Srf-Nestin-cKO mice compared with control mice. Scale bar, 
20μm. 
 
The proper lamination of the neocortex in Srf-Nestin-cKO mice suggested 
that radial migration of neurons is not affected in the absence of SRF. We found 
that SRF is also deleted in radial glial cells in Srf-Nestin-cKO mice (data not 
shown). We immunostained P0.5 brains using anti-vimentin antibody, which 
labels radial glial processes, and found no gross alteration in the abundance of 
radial glial processes or the integrity of projections within multiple regions 
examined including the ventricular zone, neocortex, hippocampus, and corpus 
callosum (Fig. 6D,E, data not shown). Together, these findings suggest that loss 
of SRF does not affect radial glial projections and thereby, the radial migration of 
neurons and lamination of neocortex. 
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SRF is not required for interneuron subtype specification 
Given the role of SRF in mediating differentiation and development of 
several cell types in other tissues, we next sought to determine whether SRF is 
required for specification of interneurons. Interneurons, which show astonishing 
differences in their electrophysiological, morphological, and molecular properties, 
are primarily derived from the medial and caudal ganglionic eminences during 
brain development and then migrate to populate the neocortex as the brain 
matures (Marín and Rubenstein, 2003; Wonders and Anderson, 2006). Since Srf-
Nestin-cKO mutants do not survive beyond P1, we restricted our analysis to 
interneuron populations in the striatum. We used immunostaining for anti-Gad-6 
to identify the expression of GAD, an enzyme that synthesizes GABA 
neurotransmitters in all interneurons (Fig. 7A). We found no significant difference 
in the overall numbers of interneurons between control and Srf-Nestin-cKO mice 
(Fig. 7A,C; control 100 ± 6.8% and knock-out 98.8 ± 10.8%). Next, we analyzed 
for different interneuron subtypes, including SSTpositive, parvalbumin-positive, 
and calbindin-positive cells. We observed no difference in their numbers between 
Srf-Nestin-cKO mutants and control littermates (Fig. 7B,C; SST+ cells: control 
100 ± 7.3% and knock-out 92.6 ± 7.5%; parvalbumin+ cells: control 100 ± 6.4% 
and knock-out 117.8 ± 11.2%; calbindin+: control 100 ± 7.8% and knock-out 
116.0 ± 10.1%).  
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Together, these findings demonstrate that, in addition to projection neuron 
subtype specification, the establishment of interneuron subtypes occurs normally 
in the absence of SRF during neuronal lineage commitment. 
 
 
Figure 7. SRF is not required for interneuron subtype specification. A, 
Immunostaining for Gad-6, which labels all GABAergic interneurons, showed 
normal expression of Gad-6 in Srf-Nestin-cKO and control mice. Inset shows 
enlarged image of a single stained neuron. B, Immunohistochemistry staining 
showing expression of SST, parvalbumin, and calbindin, which label unique 
subtypes of interneurons, suggests no apparent change in the population of  
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interneurons in brains of Srf-Nestin-cKO mice. The striatal region from control 
and mutant is shown as magnified images. Inset shows enlarged image of a single 
stained neuron. C, Quantification of cell numbers for different interneurons 
subtypes for B. Student’s t test showed no statistically significant difference in the 
number of each interneuron subtype between paired control and knock-out 
animals. Error bars represent SEM. 
 
Neural precursor cell population increases in Srf-Nestin-cKO mutant mice 
Quiescent cells that rest in the G0 state can be induced by extracellular 
stimuli to express immediate early gene (IEG) programs (Herschman, 1991). A 
number of transcription factor-encoding IEGs, such as cFos, c-Myc, Egr-1, and 
JunB, and are then responsible for activating gene cascades that enable cell 
progression to the G1 state (Greenberg and Ziff, 1984; Lau and Nathans, 1985). 
SRF-mediated transcription was demonstrated to be necessary for inducing IEG 
expression in embryonic stem cells and in neurons (Norman et al., 1988; Schratt 
et al., 2001; Ramanan et al., 2005). Sequestration of functional SRF was also 
shown to impede rat embryonic fibroblast and myoblast proliferation, but not self-
renewal of embryonic stem cells (Gauthier-Rouvie`re et al., 1991; Soulez et al., 
1996). We therefore assessed whether SRF deletion affects NPC growth and 
maintenance in vivo. Proliferating progenitor cells are identified by the expression 
of phospho-histone H3, which is a modification event that occurs specifically 
during cell division events of both mitosis and meiosis (Hans and Dimitrov, 2001).  
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Surprisingly, we observed an increase in phosphohistone H3-positive cells 
in the proliferative subventricular zone (SVZ) of Srf-Nestin-cKO brains at both 
E14.5 and E18.5 (Fig. 8A–D). Quantitative analyses of the number of phospho-
histone H3-positive cells per area of the parameter of the SVZ revealed a 20% and 
80% increase in mutants at E14.5 and E18.5, respectively (Fig. 8E; E14.5 p-
histone H3 normalized: control 100 ± 7.3% and knock-out 120.7±7.8%; and 
E18.5 p-histone H3 normalized: control 100 ± 3.0% and knock-out 180.6 ± 4.2%). 
We confirmed the increase in proliferative progenitor cell numbers using two 
additional markers: Ki-67, which is expressed by cells in the cell-cycle phases G1, 
S, and G2 and in mitosis; and Sox2, a transcription factor expressed in NPC. At 
E14.5, immunohistochemistry staining of Ki-67 in Srf-Nestin-cKO brains showed 
an increase in NPC numbers per square micrometer in the SVZ and the neocortex 
compared with control (Fig. 8E,F; Ki-67 normalized: control 100 ± 18.0% and 
knock-out 140 ± 6.3%). Similarly, neocortex and SVZ in Srf-Nestin-cKO showed 
markedly increased numbers of Sox2-expressing cells compared with those in 
control littermates (Fig. 8F). These observations suggest that loss of SRF affects 
NPC homeostasis during development without affecting NPC survival. 
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Figure 8. Loss of SRF results in an increase in the number of neural precursor 
cells. A, Proliferating NPCs are identified in the control and Srf-Nestin-cKO 
forebrains using anti-p-histone H3 antibody at E14.5. B, Magnification of the 
boxed regions in A. C, Comparison of NPC populations at E18.5. D, Magnified 
view of the boxed regions in C. E, Cell count analyses of the number of p-
histone-H3- and Ki67-positive cells at E14.5 indicate a statistically significant 
increase in the number of proliferating cells in the ventricular zone of Srf-Nestin-
cKO mice. The difference in relative numbers of NPCs between the control and 
mutant brain is more pronounced at E18.5. F, Immunostaining for two additional 
proteins, Ki67, a marker of cells in the active phase of cell cycle, and Sox2, a 
marker of neural precursor cells, was used to visualize proliferating cells in the 
neocortex at E14.5. Mutant brains not only display more Ki67-positive cells but 
also show a broadened layer of Sox2-positive cells. Scale bars, 50μm. 
 
Conditional deletion of SRF in developing forebrain neurons 
Our analyses of the Srf-Nestin-cKO mice suggested that SRF plays a 
specific role in the development of axonal tracts without affecting neurogenesis, 
neuronal survival, and neuronal subtype specification. However, since SRF 
deletion occurs in all neural precursor cells before cellular differentiation occurs, 
it is possible that axon growth defects in Srf-Nestin-cKO mice could be due to a 
non-cell autonomous requirement of SRF for axon growth. To ascertain whether 
SRF is required cell autonomously for axon growth, we generated a neuron- 
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specific deletion of SRF using the NEX-Cre transgenic mouse. In the NEX-Cre 
mouse, cre expression is controlled by the onset of expression of the NEX gene 
(also known as Math2 or NeuroD6), an early neuronal basic helixloop- helix gene 
expressed specifically in differentiating neurons (Schwab et al., 1998; Goebbels et 
al., 2006). Cre recombinase-mediated excision in the NEX-Cre mouse has been 
shown to take place starting at ~E11.5 and is restricted only to the glutamatergic 
neurons in the neocortex and hippocampus, whereas cre expression is not 
observed in the interneurons and glial cells (Brockschnieder et al., 2004; 
Goebbels et al., 2006; Kashani et al., 2006). The Srf-NEX-cKO mice were born in 
the expected Mendelian ratio but unlike the Srf-Nestin-cKO mice, these mice did 
not exhibit neonatal lethality and grew to adulthood. We first confirmed deletion 
at P0.5 by immunostaining and found that SRF deletion was restricted to the 
neocortex and hippocampus but not in the striatum and other regions of the brain, 
consistent with previous findings (Fig. 9A—D, data not shown). We next asked 
whether lamination occurs normally in Srf-NEX-cKO mice. We performed 
immunostaining for laminar-specific markers, Cux1 and Tbr1, on P21 brains. We 
did not find any deficits in neocortical lamination in Srf-NEX-cKO mice as 
compared with control littermates (Fig. 9E). At birth, the lack of defects in 
lamination in Srf-NEX-cKO mice was similar to that observed for Srf-Nestin-cKO 
mutant mice (data not shown).  Together, these findings suggest neocortical 
lamination is properly established in the absence of SRF. 
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Figure 9. Ablation of SRF in Srf-NEX-cKO. A, Immunofluorescence staining at 
P0.5 using anti-SRF antibody shows that SRF is deleted in the neocortex but not 
in the striatum of Srf-NEX-cKO mutants. B, Magnified views of boxed regions in 
A. C, SRF expression is also abolished in the hippocampus in mutants. D, A 
magnified view of CA3 neurons of control and Srf-NEX-cKO mice. E, 
Immunostaining of P21 brains using anti-Tbr1 and anti-Cux1 shows normal 
lamination of neocortex in Srf-NEX-cKO mice and control littermates. Scale bars, 
50μm. 
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SRF mediates cortical neuron target innervation cell autonomously 
We next analyzed axonal projections in Srf-NEX-cKO mice at P0.5 using 
DiI labeling. Two weeks following DiI labeling, sagittal sections of Srf-NEX-
cKO mouse brains revealed greatly diminished corticospinal projections, and 
cortical motor neuron axons passing through the internal capsule were less 
abundant with very few projections reaching the cerebral peduncle (Fig. 
10A,A’,A”; n = 3 mice). Comparison of parallel serial sections from the lateral 
side to the medial region of the forebrain between control and Srf-NEX-cKO mice 
showed a severe reduction in corticospinal projections in the mutant neocortex 
(Fig. 10B; n = 3 mice). We then examined horizontal sections of control and Srf-
NEX-cKO brains after 6 weeks of DiI labeling. Onthe ventral side of the brain, 
we observed that the intracortical and corticostriatal connections in Srf-NEX-cKO 
mice were less abundant and shorter than those observed in control littermates. In 
particular, a region of the thalamus is clearly innervated in the control brain; 
however, this innervation is less prominent in the Srf-NEX-cKO brain (Fig. 10C; 
n = 3 mice). In the medial region of the brains, similar to that observed in 2-week-
old sagittal sections, it was evident that corticospinal innervations through the 
striatum to the cerebral peduncle were greatly reduced overall in Srf-NEX-cKO 
mutants compared with control littermates (Fig. 10D). We further examined serial 
coronal sections of control and Srf-NEX-cKO brains at 4 weeks after DiI labeling. 
In rostral sections, DiI tracing showed that callosal innervations that form the 
corpus callosum are diminished and shorter in the Srf-NEX-cKO brains (Fig. 10E).  
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We found less abundant corticostriatal projections in the Srf-NEX-cKO brain (Fig. 
10E,F; projection area: control, 205,737 ± 496 µm2; Srf-NEX cKO, 12,148 ± 427 
µm2, n = 3 mice), an observation that is consistent with that made in brains of Srf-
Nestin-cKO mice using anti-2H3 immunostaining. Toward the caudal end of the 
forebrain, retrograde DiI labeling revealed that the corticothalamic connections, 
which are important relays of sensory information between the visual cortex and 
the lateral geniculate nucleus of the thalamus, were also less robustly established 
in the Srf-NEX-cKO mice compared with control mice (Fig. 10E,F; projection 
area: control, 41,690 ± 1643 µm2; Srf-NEX-cKO, 21,229 ± 1207 µm2, n = 2 
mice). These observations were consistent in all the mutant mice analyzed.  
These neuroanatomical tracing experiments demonstrate that SRF plays a 
critical cell-autonomous role in regulating axonal growth and establishment of 
axonal projections in vivo.  
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Figure 10. Dil labeling shows impairment in axonal projections in Srf-NEX-cKO 
mutants. A, DiI crystals were placed on the brain surface in the regions of the 
motor and the visual cortices (indicated by asterisks) in P0.5 Srf-NEX-cKO  
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knock-out and control littermates. Two weeks after labeling, brains were 
sectioned sagittally. Impaired corticospinal innervation was observed in the 
knock-out brain. Magnifications of the internal capsule (i.c) and cerebral peduncle 
(c.p) regions are shown in A’ and A”. Projections through the cerebral peduncle 
are seen in the brains of control but Srf-NEX-cKO mice.B, Serial sagittal sections 
from lateral to medial regions of the brain show lack of corticostriatal projections 
(arrows) in Srf-NEX-cKO mice. No misguided axons were observed in the mutant 
mice. C, After 6 weeks of labeling, control and Srf-NEX-cKO brains were 
sectioned horizontally. Arrows show diminished projections within the neocortex, 
corticostriatal projections, and innervations to the thalamus in the mutant. Medial 
horizontal section shows impaired projections through the internal capsule and the 
cerebral peduncle. D, Magnified views of the boxed regions in C showing the 
corticospinal projections. E, Coronal sections from caudal regions of the brain 
reveal diminished corticostriatal as well as corticothalamic tracts (arrows). 
Asterisks indicate sites of crystal placement; dotted lines outline the ventricular 
zone and the hippocampus (H). F, Quantification of area of innervation by 
corticostriatal and corticothalamic axons in E (n = 3 mice). 
 
Discussion 
Neuronal development in the CNS involves several critical stages 
including neurogenesis and maturation of neurons, growth and extension of axons, 
and structural organization within the brain. Our current understanding of the role  
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of SRF in neuronal development comes mainly from studies using mice carrying 
conditional neuron-specific deletion of SRF in late gestation or in postnatal brain. 
However, the requirement of SRF for early stages of neuronal development 
remains unknown. In the present study, we show that conditional deletion of SRF 
in neural precursor cells (Srf-Nestin-cKO) results in severe deficits in the 
development of major axonal projections in the forebrain, including corticospinal, 
corticothalamic, corticostriatal, and thalamocortical tracts along with a variable 
loss of the corpus callosum. Axonal deficits were seen as early as E14.5 in the 
Srf-Nestin-cKO mice and there was little or no cell death during development.  
Interestingly, there was a significant increase in the number of 
proliferating cells in the ventricular zone in Srf-Nestin-cKO mice. Conditional 
deletion of SRF in embryonic forebrain neurons (Srf-NEX-cKO) also resulted in 
severe deficits in major axonal projections. Neurogenesis, radial neuronal 
migration in the neocortex, neocortical lamination, and neuronal subtype 
specification  were unaffected by SRF loss. Together, these findings suggest that 
SRF is required in a cell-autonomous manner for axon growth and extension. 
 Similar to that observed in mice with prenatal and postnatal deletion of 
SRF, SRF is dispensable for neuronal survival. Our study identifies a specific role 
for SRF in promoting axon growth during neuronal development without 
affecting neurogenesis and neuronal differentiation. Previous studies have shown 
that neuron-specific SRF deletion during late gestation in the brain causes deficits 
in terminal targeting of mossy fiber axons in the hippocampus, while SRF loss in  
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developing sensory neurons in the peripheral nervous system affects NGF-
dependent terminal arborization and target innervation (Kno¨ll et al., 2006; 
Wickramasinghe et al., 2008). However, proximal axon growth in the peripheral 
nervous system is not affected while the role of SRF in axon growth in the CNS 
remains unknown. We found that deleting SRF in neural precursor cells results in 
severe deficits in axon growth and targeting of cortical axon projections. 
Observations made in cultured hippocampal neurons have shown that SRF is 
required for contact-mediated axon repulsion (Kno¨ll et al., 2006). We did not 
observe any mistargeted axonal tracts in the brains of Srf-Nestin-cKO mice, 
suggesting that the lack of target innervation seen in the SRF mutant mice is 
primarily due to defects in axon growth and not due to defects in axon 
guidance.Wefound similar axonal growth defects when SRF was deleted in 
developing postmitotic neurons in neocortex and hippocampus in Srf-NEX-cKO 
mutant mice. Unlike Srf-Nestin-cKO mice, the Srf-NEX-cKO mice survived to 
adulthood, and in preliminary observations, we found that adult Srf-NEX-cKO 
mice exhibited clasping of limbs in a dystonic manner when subjected to the tail 
suspension test, which is suggestive of motor dysfunction (Carter et al., 1999; 
Yamamoto et al., 2000). Furthermore, consistent with previous observations, we 
also found that SRF-deficient neurons exhibit highly attenuated axon growth in 
culture (Kno¨ll et al., 2006) (C. Li and N. Ramanan, unpublished observations).  
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The similarities in deficits in axon growth in the brains of Srf-Nestin-cKO and 
Srf-NEX-cKO mice suggested that SRF-dependent transcription plays a cell-
intrinsic role in axon growth. 
The molecular mechanisms underlying SRF-dependent axon growth 
remain poorly understood. One mechanism by which SRF potentially regulates 
axon growth is through association with specific cofactors. We found that 
blocking the functions of the Ternary Complex Factor-family cofactors of SRF, 
including Elk-1, does not affect axon growth in cultured neurons (C. Li and N. 
Ramanan, unpublished observations). However, we and others have found that 
blocking the functions of myocardin-family cofactors, MKL1 (also known as 
MAL/MRTF-A) and MKL2 (MRTF-B), by dominant-negative or knockdown 
approaches or by gene deletion attenuates axon growth in vitro (Kno¨ll et al., 
2006; Shiota et al., 2006; Wickramasinghe et al., 2008; Mokalled et al., 2010) (C. 
Li and N. Ramanan, unpublished observations). Mutant mice that lack both 
MKL1 and MKL2 in the brain exhibit deficits in dendritic growth in the 
neocortex and hippocampus as assessed by MAP2 and Golgi staining (Mokalled 
et al., 2010). However, the effect of MKL1/MKL2 loss on axon growth in vivo 
has not been reported in these mice. In the peripheral nervous system, SRF has 
been shown to function downstream of NGF signaling to regulate terminal 
arborization of axons and target innervation (Wickramasinghe et al., 2008).  
 
 
63 
 
Chapter 2: SRF in neurons 
Furthermore, NGF signaling to SRF is dependent on both ERK/MEK and 
MAL/MKL1 signaling pathways. The findings from the peripheral nervous 
system raise an interesting question as to which extracellular signals might 
stimulate SRF-dependent transcription during axon growth in the brain. Currently 
we lack sufficient knowledge on the nature of the extracellular signals and the 
identities of SRF target genes critical for axon growth in the CNS. It is likely that 
SRF functions downstream of growth factors such as BDNF to regulate axon 
growth. SRF could also regulate axon growth by regulating the expression of 
components of the actin cytoskeleton, including β-actin, γ-actin, paxillin, vinculin, 
and talin (Schratt et al., 2002). In fact, previous studies including our own have 
shown that β-actin expression is reduced in SRF knock-out neurons (Alberti et al., 
2005;Ramananet al., 2005;Kno¨ll et al., 2006), and it was hypothesized that 
reduction in actin levels was one of the underlying causes for neurite outgrowth 
deficits observed in SRFdeficient neurons. However, overexpression of actin was 
found to be insufficient to rescue the growth deficits of SRF-null neurons (Kno¨ll 
et al., 2006; Stern et al., 2009). Since SRF regulates the expression of several 
cytoskeletal proteins (Schratt et al., 2002), it is possible that the neuronal growth 
deficits exhibited by SRF-deficient neurons could be due to a breakdown in 
cytoskeletal apparatus critical for growth and extension. 
We did not observe any increased cell death in the brains of Srf-Nestin-
cKO and Srf-NEX-cKO mutant mice during development. There was also no 
noticeable difference in neuronal cell numbers in older Srf-NEX-cKO mice, and  
64 
 
Chapter 2: SRF in neurons 
this is consistent with our previous findings that SRF deletion does not result in 
cell death or neurodegeneration in the CNS (Ramanan et al., 2005). Interestingly, 
SRF deletion in neural precursor cells did not cause apoptotic cell death, a 
phenotype that contrasts with observations made in SRF-deficient embryonic 
stem cells (Schratt et al., 2004). SRF-deficient mouse ES cells exhibited apoptotic 
cell death both in vitro and in vivo (Schratt et al., 2004). Our findings suggest that 
SRF is dispensable for survival of NPCs both in vitro and in vivo (our 
unpublished observations). In contrast, we observed an increase in the total 
number of p-histone-H3 and Sox2-positive cells in Srf-Nestin-cKO mice.  
A recent elegant study showed that SRF deletion in neurons affects 
oligodendrocyte differentiation in a paracrine manner (Stritt et al., 2009). 
Consistent with this observation, we also observed a decrease in Olig2+ cells at 
birth in Srf-Nestin-cKO mice (our unpublished observations). Therefore, a likely 
explanation for the increase in NPC numbers in Srf-Nestin-cKO mice is that SRF 
loss in NPCs affects oligodendrocyte differentiation, thereby resulting in an 
increase in undifferentiated neural precursor cells.  Together, these observations 
suggest that there are distinct requirements for SRF in ES cells and in NPCs for 
cell survival. 
Previous studies have shown that SRF has a profound role in regulating 
cell-type specific gene expression that underlies the development of many cell 
types. A number of tissue-specific inactivation studies later elucidated essential 
functions of SRF for the development of cardiac muscle cells (Niu et al., 2005, 
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2008; Zhao et al., 2005), the differentiation of smooth muscles (Miano et al., 2004; 
Parlakian et al., 2004), and the normal proliferation and differentiation of 
keratinocytes (Koegel et al., 2009). We observed no differences in total number of 
NeuN-positive cells in Srf-Nestin-cKO mice, suggesting that SRF is dispensable 
for neurogenesis in the brain.We also found that neuronal subtype specification 
and both interneuron and neocortical lamina-specific neuron identities were 
properly established in the absence of SRF.  
The findings that SRF-deficient neurons negatively influence 
oligodendrocyte differentiation suggest that SRF-dependent transcription can 
promote cell-type specification in the brain (Stritt et al., 2009). SRF deletion in 
developing neurons has been shown to affect tangential cell migration along the 
rostral migratory stream (Alberti et al., 2005). We also observed similar tangential 
migration deficits in the Srf-Nestin-cKO mice (our unpublished observations). 
However, we found that radial migration of neurons in the neocortex was not 
affected and neocortical lamination was established normally in both Srf-Nestin-
cKO and Srf-NEX-cKO mutant mice. Our observations differ from those of a 
recent study in which cortical lamination was shown to be affected in mice 
carrying neuron-specific deletion of SRF (Stritt and Kno¨ll, 2010). In this study, 
calbindin-positive cells were reduced in SRF-mutant neocortex while 
immunostaining for the neurofilament protein SMI-32, which also labels a 
subpopulation of cortical neurons (Campbell and Morrison, 1989) in layers III and 
V, showed mislocalization of Smi-32-positive cells between layers III and V.  
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Calbindin-positive interneurons are mainly generated in the medial ganglionic 
eminences before they tangentially migrate to populate the neocortex (Marín and 
Rubenstein, 2003; Wonders and Anderson, 2006), and we did not find any change 
in the total numbers of striatal calbindin-positive cells in Srf-Nestin-cKO mice at 
birth. In this study, we used both in situ hybridization and immunohistochemistry 
for several transcription factors that are expressed in specific cortical layers 
during mouse development (Gray et al., 2004). We did not find any lamination 
defects in the neocortex of either Srf-Nestin-cKO or Srf-NEX-cKO mice at P0.5 
or in 3-week-old Srf-NEX-cKO mice. If SRF is critical for neocortical lamination, 
then this phenotype should be more severe in the Srf-Nestin-cKO mice, since SRF 
is deleted in all major cell types in the brain starting at E12.5 (our unpublished 
observations).  
Based on our observations, we conclude that SRF loss in neural precursor 
cells and in developing neurons does not affect layering of the neocortex. We also 
found that SRF deletion in radial glial cells in Srf-Nestin-cKO mice did not affect 
their morphology, suggesting that SRF-dependent transcription is not required for 
extension of radial glial processes. 
Our study identifies specific roles for SRF during neuronal development. 
SRF plays a critical role in neural precursor cell homeostasis and in the formation 
of major axonal tracts in the brain. SRF is dispensable for neurogenesis and cell 
survival but contrary to recent findings, SRF is not required for neocortical 
lamination. 
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Chapter 3:  SRF in Astrocyte and Oligodendrocyte Specification 
This chapter is adapted from a revised manuscript for the Journal of Neuroscience, 
to be submitted in April, 2012. 
A Critical Cell-intrinsic Role for Serum Response Factor in Glial 
Specification in the CNS 
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ABSTRACT 
Astrocytes and oligodendrocytes play crucial roles in nearly every facet of 
nervous system development and function including neuronal migration, 
synaptogenesis, synaptic plasticity, myelination and maintenance.  Previous 
studies have widely characterized the signaling pathways important for 
astrocyte differentiation and unveiled a number of transcription factors that 
guide oligodendrocyte differentiation in the CNS.  However, the identities of 
the transcription factors critical for astrocyte specification in the brain 
remain unknown.  Here we show that deletion of the stimulus-dependent 
transcription factor, serum response factor (SRF) in neural precursor cells 
(Srf-Nestin-cKO) results in nearly 60% loss in astrocytes and 50% loss in 
oligodendrocyte precursors at birth.  Cultured SRF-deficient neural 
precursor cells (NPCs) exhibited normal growth rate and capacity to self-
renew.  However, SRF-deficient NPCs generated fewer astrocytes and 
oligodendrocytes in response to several lineage-specific differentiation factors.  
These deficits in glial differentiation were rescued by ectopic expression of 
wild type SRF in SRF-deficient NPCs.  Interestingly, ectopic expression of a 
constitutively active SRF, (SRF-VP16) augmented astrocyte differentiation in 
the presence of pro-astrocytic factors.  However, SRF-VP16 expression in 
NPCs had an inhibitory effect on oligodendrocyte differentiation as 
previously reported.  In contrast, mice carrying conditional deletion of SRF 
in developing forebrain neurons (Srf-NEX-cKO) did not exhibit any deficits  
77 
 
Chapter 3: SRF in Glial Development 
in astrocytes in the brain.  Together, our observations suggest that SRF plays 
a critical cell-autonomous role in NPCs to regulate astrocyte and 
oligodendrocyte specification both in vivo and in vitro. 
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INTRODUCTION  
Astrocytes play multiple critical roles in brain development and 
functioning (Barres, 2008), and abnormalities in astrocyte development have been 
implicated in neurological disorders including epilepsy, neurodegenerative 
disorders and brain tumors (Lobsiger and Cleveland, 2007; Oberheim et al., 2008).  
On the other hand, oligodendrocytes are essential for myelination (Hirano, 1968; 
Emery, 2010), and dysregulated myelination causes multiple sclerosis and 
leukodystrophy (Emery, 2010).  It is of critical importance to elucidate the 
molecular mechanisms regulating astrocyte and oligodendrocyte specification and 
development in the brain.   
The onset of astrocyte specification begins towards the end of 
neurogenesis (Okano and Temple, 2009b).  In the CNS astrogenesis is regulated 
by several ligand-receptor complexes (Freeman, 2010).  Widely studied cytokines 
among them include ciliary neurotrophic factor (CNTF), leukemia inhibitory 
factor (LIF), and cardiotrophin-1 (CT-1), which activate JAK/STAT pathway to 
promote astrocyte differentiation (Johe et al., 1996; Bonni et al., 1997; Rajan and 
McKay, 1998; Barnabe-Heider et al., 2005).  Activation of BMP2/4 signaling, 
which results in phosphorylation of SMAD transcription factors, also regulates 
the expression of astrocyte-specific genes through interactions with STAT3 
(Nakashima et al., 1999).  However, perturbation of JAK-STAT signaling caused 
only a 45-70% reduction in astrocytes in vivo, suggesting contributions from other 
pathways.  Notch is another widely studied pathway with gain-of-function studies  
79 
 
Chapter 3: SRF in Glial Development 
showing that Notch receptors play a permissive role in NPCs promoting astrocyte 
differentiation (Morrison et al., 2000; Tanigaki et al., 2001; Gaiano and Fishell, 
2002). 
Transcriptional control of astrocyte specification has been studied mainly 
in the spinal cord.  Ablation of Sox9 causes deficits in both astrocyte and 
oligodendrocyte generation (Stolt et al., 2003), whereas nuclear factor I-A/B 
(NFIA/NFIB) and, bHLH transcription factors, stem cell leukemia (SCL) and 
KLF15 were found to be necessary and/or sufficient for astrocyte specification 
(Muroyama et al., 2005; Deneen et al., 2006; Fu et al., 2009). 
Oligodendrocyte specification occurs at late embryonic and early postnatal 
periods (Miller, 1996; Lee et al., 2000). Extracellular sonic hedgehog (Shh) signal 
in ventral telencephalon is necessary and sufficient for inducing the commitment 
to oligodendrocyte precursors (Alberta et al., 2001; Tekki-Kessaris et al., 2001). 
Downstream to Shh signaling, two bHLH transcription factors, Olig1 and Olig2, 
are particularly important for oligodendrocyte development (Lu et al., 2001; Zhou 
et al., 2001; Lu et al., 2002; Zhou and Anderson, 2002).  Besides, members of 
SRY-related HMG box family (Sox) family of transcription factors, namely Sox9, 
Sox10, and Sox17, have were found pivotal for oligodendrocyte specification 
(Stolt et al., 2002; Stolt et al., 2003; Sohn et al., 2006).  Ying Yang 1 (YY1) was 
one of the few transcription factors discovered within the brain to be crucial for 
oligodendrocyte differentiation (He et al., 2007).   
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Despite these advances in mapping the molecular machineries for astrocyte 
and oligodendrocyte specification, the identities of regulatory transcription factors 
important for glia development in the brain is far from complete.  SRF is a 
stimulus-dependent transcription factor required for differentiation and 
development of several different cell types including keratinocytes, cardiac and 
smooth muscle cells (Miano et al., 2004; Parlakian et al., 2004; Niu et al., 2005; 
Verdoni et al., 2010).  Within the CNS, SRF regulates axon growth, tangential 
neuronal migration, activity-dependent gene expression, synaptic plasticity and 
learning and memory  (Ramanan et al., 2005; Etkin et al., 2006; Knoll et al., 2006; 
Stern et al., 2009; Johnson et al., 2011; Lu and Ramanan, 2011a).  Here, we report 
a previously unidentified role for SRF in   astrocyte and oligodendrocyte 
differentiation in the brain.   
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MATERIALS AND METHODS 
Animals.  Srf f/f mice (control) were maintained as a homozygous colony as 
described (Ramanan et al., 2005).  The Srf-Nestin-cKO and Srf-NEX-cKO were 
generated as described (Lu and Ramanan, 2011a) using a Nestin-Cre transgenic 
mouse line (Tronche et al., 1999) and a NEX-Cre line (Goebbels et al., 2006).  
The Srf f/+;Nescre double heterozygous mice did not exhibit any discernible 
phenotype.  Pups of either sex (n=3-5) from at least two different litters were used 
in all experiments.  All experiments were approved by the Animals Studies 
Committee, Division of Comparative Medicine, Washington University School of 
Medicine, St. Louis, MO. 
 
Immunostaining, cell counts and statistical analyses.  Immunohistochemistry was 
performed as described (Ramanan et al., 2005).  Primary antibodies used were: 
Aldh1L1 (1:100, NeuroMab), S100β (1:1000, Sigma-Aldrich), GFAP/G-145 
(1:1000, Sigma-Aldrich), SRF (1:1500, Santa Cruz), Nestin (1:200, DHSB), 
Tuj1/β-tubulin III (1:1000, Sigma-Aldrich), APC (1:1000, Millipore), β-gal 
(1:1500, Aves Lab), O4 (1:750, Millipore), Olig2 (1:1000, Sigma-Aldrich), Olig1 
(1:50, NeuroMab), activated-Caspase 3 (1:1500, Millipore), and Sox2 (1:100, 
Santa Cruz).  Secondary antibodies used were: anti-goat Cy3 (1:300, Jackson 
ImmunoResearch), anti-mouse Alexa Fluor (AF) 594 and AF488, and anti-rabbit 
AF488 and AF 594 (1:500, Invitrogen).  Biotinylated anti-rabbit and anti-mouse 
secondary antibodies (1:500, Vector Labs) were used along with ABC-Elite or  
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VIP staining kits (Vector Labs).  Cell count and statistical analyses were 
performed as previously described (Lu and Ramanan, 2011).  
 
Western blotting.   25 µg of total protein prepared from neurospheres was 
immunoblotted by standard procedures.  Primary antibodies were anti-SRF, 
1:5000 (Santa Cruz), anti-tubulin, 1:10,000 (Sigma-Aldrich).  Secondary 
antibodies include anti-HRP (1:20,000; anti-mouse, Jackson ImmunoResearch 
and anti-rabbit, Invitrogen). Chemiluminescence detection was done using 
Immobilon reagent (Millipore).  
 
Neurosphere culture.  Neurosphere cultures and culture media were prepared as 
described (Dasgupta and Gutmann, 2005).  Neonatal cortices were dissected and 
trypsinized at 37°C for 15 min.  Cells were mechanically dissociated by pipetting 
and incubated in 10% fetal calf serum medium for 10 min and pelleted by 
centrifugation.  Dissociation medium was used to wash the cells before 
resuspending in growth medium containing 1:4000 dilution of 20 μg/ml FGF and 
EGF.  Samples were at cultured 250,000–500,000 cells per 60-mm dish at 37°C 
with 5% CO2 for 4 days. 
 
NPC proliferation analysis.  Srf f/f, Srf f/+;NesCre, and Srf f/f;NesCre mice-derived 
neurospheres were dissociated by trypsin digestion and seeded singly in 24-well 
plate with fresh growth medium.  Every 12hr, neurospheres from triplicate wells  
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were collected, dissociated, and cell counts determined.  Cell growth was 
monitored over 84 hours, and results plotted with sample mean and SEM.  The 
experiment was repeated thrice using NPCs generated from animals from 
different litters. 
 
Secondary neurosphere analysis.  NPCs from control and Srf-Nestin-cKO brains 
were grown as neurospheres.  After 4 DIV, neurospheres were dissociated and 
seeded as single cells.  About 50-70 single NPCs from each background were 
plated in 96-well plate and grown in fresh growth medium.  The number of new 
neurospheres was monitored every 24 hr and over 5 days to measure the 
percentage of cells that gave rise to a secondary neurosphere.  The experiment 
was repeated twice using animals from different litters. 
 
NPC differentiation.  Neurospheres were trypsinized and washed with 
dissociation medium and were plated at 150,000 cells/well in 24-well plates in 
differentiation medium (growth medium without FGF and EGF).  To enrich for 
astrocytes, the following pro-astrocytic growth factors and cytokines were 
supplemented either individually or collectively: CNTF, 100 ng/ml; LIF, 40 ng/ml; 
CT-1, 50 ng/ml; BMP-2, 30 ng/ml; IL6, 20 ng/ml; sIL6R, 25 ng/ml; and JAG-1, 
500 ng/ml.  Cells were fixed using 4% sucrose in 4% paraformaldehyde (PFA) in 
phosphate buffered saline and immunostained 4 days after induction.  To enrich 
for oligodendrocytes, PDGF, 10 ng/ml, and trtriiodothyronine (T3), 30 ng/ml,  
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were added to trypsinized NPCs.  The percentage of OPCs generated was 
analyzed at 2 days post-induction and the percentage of differentiation 
oligodendrocytes derived was analyzed at 4 days post-induction.  
 
Generation of MSCV virus.  The retroviral murine stem cell virus vector encoding 
GFP (MSCV-GFP) was obtained as gift from Dr. David Gutmann Lab at 
Washington University School of Medicine (Dasgupta and Gutmann, 2005).  We 
cloned wildtype SRF (SRFwt) and a constitutively active variant of SRF (SRF-
VP16) into MSCV-GFP separately.  Viruses were produced by using Fugene HD 
(Roche) to introduce the MSCV constructs and the complementary T-helper (gift 
of Dr. David Gutmann Lab) into 293T cells and collecting filtered viral medium 
at 48 hours and 72 hours.  Infections were accomplished by providing 80% viral 
supernatant and 20% fresh NPC growth medium to NPCs for 2 days and then 
switching to 100% NPC growth medium for another 3 – 4 days before 
trypsinizing the neurospheres for differentiation induction.  The empty MSCV-
GFP construct was used as a control for analyzing the effects of MSCV-SRFwt 
and/or MSCV-SRF-VP16 in rescue experiments.      
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RESULTS 
SRF ablation results in reduced astrocyte numbers in vivo 
 SRF has been shown to regulate cell-fate specification in a cell-
autonomous manner in several organ systems in mice (Miano et al., 2004; 
Parlakian et al., 2004; Sandbo et al., 2009; Verdoni et al., 2010) but whether SRF 
has similar roles in the nervous system has remained unexplored.  To address this, 
we conditionally deleted SRF within NPCs using a Nestin-cre transgenic mouse 
line (Srf-Nestin-cKO) (Lu and Ramanan, 2011).  The Srf-Nestin-cKO mice died 
neonatally and did not exhibit any defects in cell survival, neurogenesis or 
neuronal subtype specification (Lu and Ramanan, 2011).  Since neurogenesis was 
unaffected in Srf-Nestin-cKO mice, we examined astrocytes at P0.5 by 
immunostaining for the astrocyte marker, GFAP.  We found that Srf-Nestin-cKO 
mice exhibited nearly 60% reduction in astrocytes in multiple brain regions 
including neocortex, hippocampus, corpus callosum, and thalamus (Fig 1A and 
data not shown).  We next assessed SRF deletion in astrocytes.  Co-
immunostaining for GFAP and SRF revealed that SRF is robustly expressed in 
astrocytes of control mice but not in Srf-Nestin-cKO mice (Fig. 1B).  We also 
confirmed that reduced astrocytes in Srf-Nestin-cKO mice were not due to 
diminished GFAP expression.  Immunostaining brain sections from Srf-Nestin-
cKO and control mice using two other astrocyte markers, Aldh1L1 (Cahoy et al., 
2008) and S100β, showed that control mice had significantly more astrocytes in  
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several brain regions including neocortex and hippocampus, compared to Srf-
Nestin-cKO mice (Fig 1C,D,E,F; n=5 mice).   
 Our recent findings revealed that Srf-Nestin-cKO mice did not exhibit any 
deficits in neurogenesis or increased apoptosis during development (Lu and 
Ramanan, 2011).  However, there was an increase in proliferative precursor cells 
in the subventricular zone in Srf-Nestin-cKO mice (Lu and Ramanan, 2011), 
which is possibly a result of impairment in glial lineage commitment.  Together, 
these findings suggest that the decrease in astrocytes in neonatal Srf-Nestin-cKO 
mice reflects a critical requirement of SRF for astrocyte differentiation in vivo.   
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Figure 1. SRF is required for astrocyte specification in vivo. (A) Astrocytes were 
immunostained using anti-GFAP antibodies.  Cell count analyses from several 
brain regions including neocortex, hippocampus, striatum and thalamus, indicate  
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a significant reduction in astrocytes in Srf-Nestin-cKO mice compared to control 
littermates (n=5 mice).  (B)  Co-immunofluorescence staining for SRF and 
GFAP shows robust SRF staining in astrocytes in control mice but not in Srf-
Nestin-cKO mice (n=4 mice). Scale bar, 10µm, shown here is hippocampus.  (C) 
Aldh1L1 immunostaining of P0.5 brain sections from control and Srf-Nestin-
cKO mice shows astrocytes in several brain regions.  Scale bar, 50 µm.  (D) 
Quantification of cell counts from (C) (n=5 mice).  (E) Immunostaining for 
S100β+ astrocytes in control and Srf-Nestin-cKO mutant mice.  Scale bar, 50 µm.  
(F)  Quantification of cell counts in (D) (n=5 mice).  
 
SRF-deficiency in neural precursor cells impairs astrocyte specification in 
vitro  
To study the role of SRF in astrocyte specification further, we used the 
neurosphere culture system (Dasgupta and Gutmann, 2005).  NPCs cultured from 
P0.5 cortices of control and Srf-Nestin-cKO brains formed neurospheres in 2-3 
days in the presence of EGF and FGF as mitogens and were physically 
indistinguishable from one another (Fig. 2A, 3A and data not shown).  Co-
immunostaining for NPC marker, Nestin, and SRF showed that neurospheres 
from control mice exhibited strong immunoreactivity for both SRF and Nestin.  In 
contrast, neurospheres from Srf-Nestin-cKO mice were positive for Nestin but 
lacked SRF (Fig. 2A).   
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Immunoblotting of total protein isolated from control and SRF-deficient 
neurospheres further confirmed SRF deletion in NPCs from Srf-Nestin-cKO mice 
(Fig. 2B).  Likewise, SRF was completely ablated in NPCs isolated from cortices 
of E12.5 Srf-Nestin-cKO mice (data not shown).  We next analyzed the effect of 
SRF deletion on NPC proliferation and found that SRF-deficient and SRF-
heterozygous NPCs had rates of proliferation comparable to NPCs from control 
mice (Fig. 2C).  We analyzed the capacity of SRF-deficient NPCs to self-renew 
by assessing their ability to form clonal secondary neurospheres from single 
NPCs.  SRF loss did not affect the capacity of NPCs to form secondary 
neurospheres (Fig. 2D).  These findings demonstrate that SRF deletion in NPCs 
does not affect NPC growth rate and capacity for self-renewal in vitro.  
NPCs are multipotent and are capable of differentiating into neurons, 
astrocytes and oligodendrocytes upon mitogen withdrawal (Gritti et al., 1999; 
Ahmed, 2009).  We found that SRF-deficient NPCs were capable of generating 
neurons, astrocytes and oligodendrocytes as identified by the expression β-
Tubulin III in neurons, GFAP in astrocytes, and the co-expression of APC 
(adenomatous polyposis coli) and O4 in differentiated oligodendrocytes  (Fig. 2E).  
Similar to in vivo observations, SRF-deficient NPCs generated significantly fewer 
astrocytes as well as differentiated oligodendrocytes whereas similar number of 
neurons was generated compared to wild type NPCs (Fig. 2F).  These results 
confirm that SRF is dispensable for neurogenesis but is critical for glial 
specification.   
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As previous studies elegantly demonstrated that SRF plays a functional 
role in neurons modulating neighboring oligodendrocyte maturation in a paracrine 
manner (Stritt et al., 2009), our results could indicate that the reduction in 
oligodendrocytes generated by SRF-deficient NPC is a consequence of 
impairment neuronal SRF-mediated oligodendrocyte maturation and/or a cell 
intrinsic requirement of SRF for oligodendrocyte specification.   
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Figure 2.  SRF-deficient neural precursor cells exhibit normal proliferation and 
self-renewal. (A) NPCs, identified by Nestin expression, were isolated from 
forebrains of P0.5 control and Srf-Nestin-cKO mice and cultured as neurospheres 
for 4 DIV.  Only neurospheres from control mice, but not Srf-Nestin-cKO mice, 
robustly express SRF. Scale bar, 50 µm.  (B) Immunoblotting of total protein  
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from cultured NPCs shows absence of SRF in neurospheres from Srf-Nestin-cKO 
(KO) brains but not control brains (C).  (C) NPCs from P0.5 control, Srf-Nestin 
heterozygous and Srf-Nestin-cKO mice were grown as neurospheres, which were 
collected at the indicated times and cell count determined.  SRF-deficient NPCs 
exhibit comparable growth rates to that of control and SRF heterozygous cells (n 
= 3).  (D) NPCs growing as neurospheres were trypsinized and the percentage of 
single cell NPC that formed a clonal neurosphere was determined at the indicated 
time points.  The ability of single SRF-deficient NPCs to generate secondary 
neurospheres was comparable to that of control NPCs (n = 3).  (E)  NPCs from 
control and Srf-Nestin-cKO mice are multipotent and could differentiate into 
neurons (Tuj1+), astrocytes (GFAP+) and mature oligodendrocytes (APC and 
O4+) upon mitogen withdrawal.  Astrocytes and oligodendrocytes derived from 
SRF-deficient NPCs are less elaborate than those from control NPCs.  Scale bar, 
10 µm.  (F)  Cell count analyses from (E) show a significant decrease in 
astrocytes and oligodendrocytes, but not neurons, derived from SRF-deficient 
NPCs 4 days post-induction. 
 
SRF-deficient NPCs fail to respond to pro-astrocytic stimuli 
 We tested the ability of SRF-deficient NPCs to generate astrocytes in the 
presence of known pro-astrocytic ligands.  Following mitogen withdrawal and in 
the presence of CNTF and LIF, wild type NPCs differentiated predominantly into 
astrocytes at 4 DIV with characteristic stellar morphology along with less than  
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0.5% neurons and oligodendrocytes (Fig. 3A, A’, A”, and data not shown).  In 
contrast, SRF-deficient NPCs generated significantly fewer astrocytes compared 
to wild type NPCs and a large proportion of cells remained spherical, precursor-
cell-like (Fig. 3A’, A”).  Furthermore, SRF-deficient astrocytes, the minor 
population of cells that does initiate GFAP expression, did not develop elaborate 
astrocytic process and the stellate morphology that were exhibited by wild type 
astrocytes.   
We also tested the ability of other cytokines and pro-astrocytic ligands, 
including cardiotrophin-1 (CT-1), interleukin-6 (IL-6), bone morphogenetic 
protein (BMP-2) 2, and Jagged-1 (Jag-1) (Kahn and De Vellis, 1994; Marz et al., 
1999; Nakashima et al., 2001; Ochiai et al., 2001; Takizawa et al., 2001a; 
Yanagisawa et al., 2001; Grandbarbe et al., 2003; Barnabe-Heider et al., 2005; 
Namihira et al., 2009).  When cultured in the presence of one of above ligands, 
SRF-deficient NPCs generated consistently and significantly fewer astrocytes 
compared to control NPCs (Fig. 3B,C), suggesting that SRF is broadly required 
for astrocyte specification, rather than being necessary for mediating a particular 
pro-astrocyte signaling transduction.  We next asked whether these cytokines and 
growth factors added together were capable of overcoming the impairment in 
astrocyte differentiation exhibited by SRF-deficient NPCs.  Immunostaining for 
anti-GFAP and anti-S100β at 4-days post-induction showed that SRF loss 
attenuated astrocyte specification even in the presence of multiple pro-astrocytic 
stimuli (Fig. 3D,E).   
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Since deletion of SRF in NPCs does not lead to an increase or impairment 
in neurogenesis but rather a decrease in astrocytes and oligodendrocytes, we 
sought to determine the fate of NPCs remaining in culture.  Immunostaining for 
Sox2, a transcription factor expressed specifically by NPCs, showed that 
compared to 63% of control cells, 76% of SRF-deficient cells were Sox2+ at 4 
days post-induction (Fig. 3D,E).  This result suggests that in the absence of SRF, 
NPCs are less able of responding to pro-astrocytic signals and consequently, more 
of them remain in the precursor-cell state.  Furthermore, we did not observe 
statistically significant increases in the number of precursor cells in these cultures 
following astrocyte induction (data not shown), a result that suggests that the 
NPCs are not actively proliferating in the absence of mitogens and hence the 
percentage of GFAP+ cells is not skewed lower because of an increase in the pool 
of proliferating SRF-deficient precursor cells.  This increase in Sox2+ cells in 
SRF-deficient cultures was similar to that observed in the brains of P0.5 Srf-
Nestin-cKO mice, which exhibited an increase in p-histone-H3+, Ki67+, and 
Sox2+ cells along the subventricular zone and in neocortex (Lu and Ramanan, 
2011a).  
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Figure 3.  SRF-deficient NPCs fail to differentiate in response to pro-astrocyte 
stimuli.  (A)  NPCs from control and Srf-Nestin-cKO mice were cultured as 
neurospheres for 4 DIV.  SRF-deficient neurospheres do not appear 
morphologically different to control neurospheres.  The neurospheres were 
trypsinized and induced for astrocyte differentiation with CNTF (100ng/ml) and 
LIF (40ng/ml) (A’, A”).  SRF-deficient NPCs generated fewer astrocytes 
compared to wild type cells as visualized by GFAP immunostaining (A”).  The 
SRF-deficient astrocytes also appeared smaller and less stellar (A’).  A’ and A” 
represent independent experiments.  Scale bars indicate 100 µm in A and 50 µm 
in A’ and A”.  (B)  NPCs from control and Srf-Nestin-cKO mice were induced 
into astrocytes by several pro-astrocytic ligands.  At 4 days post-induction, SRF-
deficient NPCs generated significantly fewer astrocytes compared to NPCs from 
control littermates as seen by GFAP immunolabeling.  Scale bar, 25 µm.  (C)  
Quantification of GFAP+ astrocytes in (B) shows that SRF is broadly required for 
astrocyte specification (n=3 experiments).  (D)  Control and SRF-deficient NPCs 
were cultured in the presence of all ligands shown in (B) and cells were 
immunostained at 4 DIV for astrocytes (GFAP and S100β) and NPCs (Sox2).  
Arrows point to S100β+ cells.  Scale bar, 25 µm.  (E) Cell count analyses for (D) 
show that loss of SRF impairs commitment to astrocytes even in the presence of 
several pro-astrocyte signals and that more SRF-deficient NPCs remain as Sox2+ 
precursors in culture. 
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SRF is required cell-autonomously for astrocyte differentiation in vivo 
 Recent observations have shown that newborn neurons and committed 
NPCs promote astrocyte specification by secreting Notch ligands, including Jag-1, 
activating Notch signaling in neighboring uncommitted NPCs (Namihira et al., 
2009).  Since, SRF is also deleted in neurons in Srf-Nestin-cKO mice, the deficits 
in astrocyte specification could be a result of the influence of SRF-deficient 
neurons.  To address whether SRF-deficient neurons contributes to the astrocyte 
specification impairment observed in Srf-Nestin-cKO brains, and hence 
understand whether SRF regulates astrocyte differentiation cell-autonomously or 
in a paracrine way, we analyzed astrocytes in Srf-NEX-cKO mice, in which SRF 
deletion was restricted to glutamatergic neurons of the neocortex and 
hippocampus starting around E11.5 (Lu and Ramanan, 2011a).  Immunostaining 
of P0.5 brains from Srf-NEX-cKO mice and control littermates using anti-GFAP 
and anti-Aldh1L1 antibodies showed no differences in the number of astrocytes 
localized in Srf-NEX-cKO mice neocortex and hippocampus compared to control 
littermates (Fig. 4A,B and data not shown).  Unlike the Srf-Nestin-cKO mutants, 
the NEX-Cre driven SRF mutants do not experience neonatal lethality; similarly, 
no deficits in astrocytic numbers was also observed in the brains of 3-month old 
Srf-NEX-cKO mice compared to control littermates (Fig. 4C,C’).   
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In sum, these observations indicate that SRF plays a cell-autonomous role 
within NPCs to promote astrocyte specification both in vitro and in vivo, and that 
SRF deletion in neurons does not have any discernible effect on astrocyte 
specification and maintenance. 
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Figure 4.  SRF deletion in neurons does not affect astrocyte differentiation.  (A)  
Brain sections from P0.5 control and Srf-NEX-cKO mice were immunostained 
using anti-Aldh1L1 antibody to label all astrocytes (arrows).  Neocortex and 
hippocampus are shown.  Scale bar, 20 µm.  (B) Quantification of Aldh1L1+ 
astrocytes from (A) shows no significant difference in astrocyte populations in 
Srf-NEX-cKO mice compared to control littermates (n=3 mice). (C) 
Immunofluorescence staining for GFAP and Aldh1L1 labeling astrocytes in 3-
month old control and Srf-NEX-cKO mice.  No GFAP+ astrocytes were seen in 
neocortex since GFAP expression in adult brain is restricted to astrocytes in the 
white matter and hippocampus but not in the neocortex.  In contrast, Aldh1L1 
labels all astrocytes including those in neocortex of both groups of mice.  Scale 
bar, 200 µm.  C’ represents magnified view of the boxed region.  Scale bar, 20 
µm.  (D)  Quantification of Aldh1L1+ astrocytes in (C) shows no significant 
difference in the neocortex and the hippocampus between Srf-NEX-cKO and 
control littermate adult mice (n=3 mice).  
 
Srf-Nestin-cKO mutants also exhibit a reduction in oligodendrocyte 
precursors 
 Although it has been shown that SRF modulates oligodendrocyte 
maturation via the secretion of connective tissue growth factor (CTGF) from 
neurons (Stritt et al., 2009), and we too observed a decrease in the number of 
differentiated oligodendrocytes in vitro, from neurosphere assays upon mitogens 
withdrawal.   
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However, what remains unknown is whether SRF-dependent transcription 
regulates oligodendrocyte specification in NPCs.  Contrary to the observation that 
loss of neuronal SRF leads to more oligodendrocyte precursors (OPC) at around 2 
weeks of age as maturation halts (Stritt et al., 2009), we observed significantly 
fewer OPCs, identified by Olig2 and Olig1 immunoreactivity (Lu et al., 2000; 
Zhou et al., 2000), in multiple regions of P0.5 Srf-Nestin-cKO brains compared to 
wild type littermate control brains (Fig. 5A,B,C,D).  These findings suggest that in 
addition to controlling oligodendrocyte maturation, SRF could also be required 
for oligodendrocyte specification. 
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Figure 5.  SRF is important for oligodendrocyte specification.  (A)  
Oligodendrocyte precursor cells (OPCs) in the brain were identified through 
immunostaining for Olig2 expression in Srf-Nestin-cKO and control mice at P0.5, 
showing neocortex, hippocampus, and the striatum.  Scale bar, 50 µm.  (B)  
Quantification of Olig2+ cells per area in (A) shows that the number of Olig2+ 
OPCs is substantially reduced in Srf-Nestin-cKO mutants.  (C)  Olig1+ OPCs 
were also analyzed at P0.5 in control and Srf-Nestin-cKO brains, showing regions 
of the anterior corpus callosum and ventricular zone.  Scale bar, 50 µm.  (D)  
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Quantification of Olig1+ cells per area in (C) also shows a significant reduction of 
OPC population in the mutant brain. 
 
SRF-deficient NPCs show impairment in oligodendrocytes specification 
 Besides neurons, astrocytes were found to promote OPC survival in vitro 
by the secretion of platelet derived growth factor (PDGF) (Gard et al., 1995).  To 
understand whether the oligodendrocyte lineage commitment deficit observed in 
Srf-Nestin-cKO brains is cell-autonomous or is a result of reduced number of 
astrocytes and/or other neuronal defects, both occur developmentally prior to 
oligodendrocyte genesis, we cultured control and SRF-deficient NPCs from 
neonatal wild type and Srf-Nestin-cKO neocortex as neurospheres.  PDGF, which 
promotes OPC proliferation (McKinnon et al., 1990; Robinson and Miller, 1996), 
and triiodothyronine (T3), which drives oligodendrocyte differentiation (Almazan 
et al., 1985), were supplemented to induce and enrich for differentiated 
oligodendrocytes.  At 4 days post-induction, we found less than 0.5% of neurons 
and astrocytes under this pro-oligodendrocyte condition (data not shown), and 
SRF-deficient NPCs generated significantly fewer differentiated oligodendrocytes, 
as identified by the cells that co-express APC and O4, than control NPCs did (Fig. 
6C, D).  Moreover, when analyzed at 2 days post-induction, we also observed 
fewer OPCs generated by SRF-deficient NPCs as indicated by the percentage of 
PDGFRα+ and Olig2+ cells compared to control NPCs (Fig. 6A, B).   
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These findings recapitulate the in vivo observations made from Srf-Nestin-
cKO brains and demonstrate that, in addition to being functionally crucial for 
maturation, SRF is necessary for oligodendrocyte specification.  
 
 
Figure 6.  SRF-deficient NPCs show impairment in oligodendrocyte specification.  
(A)  Control and SRF-deficient NPCs were induced for oligodendrocyte lineage 
commitment using T3 (10 ng/ml) and PDGF (2.5 ng/ml).  At 2 DIV, OPC were 
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identified by Olig2 or PDGFRα positive immunoreactivity.  Scale bar, 25 µm.  (B)  
Quantification of PDGFRα+ or Olig2+ cells show that SRF-deficient NPCs 
exhibit a reduced capacity for giving rise to OPCs.  (C)  At 4 DIV, differentiated 
oligodendrocytes were identified from APC and O4 co-expression; magnified 
images of co-localization of APC and O4 staining are shown in (C’).  Arrows 
point to only O4+ positive late-OPCs.  Myelinating mature oligodendrocytes were 
identified from MBP expression (C”).  Scale bar, 25 µm in (C) and (C”) and 10 
µm in (C’).  (D)  Cell count analysis demonstrates that at 4 DIV the number of 
differentiated oligodendrocytes is also significantly reduced in SRF-deficient 
NPC cultures, thus recapitulating the in vivo phenotype of Srf-Nestin-cKO 
mutants. 
 
Ectopic expression of SRF rescues both astrocyte and oligodendrocyte 
specification in SRF-deficient NPCs 
 We questioned whether the astrocyte and the oligodendrocyte 
specification defects could be rescued by reintroduction of functional, wildtype 
SRF or are the cells fundamentally impaired in the absence of SRF.  We cloned 
the SRF gene into a murine stem cell virus vector tagged with GFP (MSCV-
SRFwt).  By analyzing for GFP expression of infected cultures of control or SRF-
deficient NPCs, we find an expression efficiency of 98 – 99% for both MSCV 
alone and, as a control, for MSCV-SRFwt (data not shown).  The addition of 
MSCV-SRFwt did not appear to influence either control or SRF-deficient NPCs’ 
proliferation rate, and we find that the expression of MSCV-SRFwt in SRF- 
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deficient NPCs is sufficient to restore the potential for astrocyte and 
oligodendrocyte differentiation, induced by CNTF and LIF and by PDGF and T3 
addition respectively, to the levels comparable to wild type NPCs (Fig. 7A, B, C, 
D). 
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Figure 7.  Re-introduction of wildtype SRF rescues glial specification defects.  (A)  
Control and SRF-deficient NPCs were harvested from P0.5 brains and were 
infected with MSCV-SRFwt or with the vector alone as a control.  NPCs were 
induced for astrocyte differentiation using CNTF and LIF and immunostained for 
GFAP expression at 4 DIV.  Scale bar, 25 µm.  (B)  Analysis of the percentage of 
astrocyte generated shows that the mere presence of MSC-SRFwt does not 
augment astrocyte specification but restores SRF-deficient NPCs’ capacity for 
astrocyte generation.  (C)  Similarly, control and SRF-deficient NPCs were 
infected with MSCV-SRFwt and induced for oligodendrocyte lineage 
commitment using PDGF and T3.  Arrows indicate APC+ and O4+ differentiated 
oligodendrocytes; arrowheads point to O4+ late-OPCs (4 DIV).  Scale bar, 25 µm.  
(D)  Quantification shows that extra copies of SRFwt do not potentiate 
oligodendrocyte differentiation in control NPCs; however, MSCV-SRFwt rescues 
the oligodendrocyte differentiation deficits of SRF-deficient NPCs. 
 
Constitutively active SRF augments the effect of astrocyte induction but is 
insufficient for inducing glial specification 
 Our results demonstrate that cell-intrinsic SRF is necessary for the proper 
cell-fate commitment to astrocyte and oligodendrocyte.  We questioned whether 
activated SRF alone is sufficient to drive NPCs cells to astrocyte and/or 
oligodendrocyte lineage: we cloned the SRF-VP16 gene – a constitutively active 
variant of SRF (Johansen and Prywes, 1994; Schratt et al., 2002) – into the MSC 
vector tagged with GFP (MSCV-SRF-VP16).   
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We find an infection and expression efficiency of ~ 98% for MSCV-SRF-
VP16 in control and SRF-deficient NPCs (data not shown).  Control and SRF-
deficient NPCs expressing either MSCV or MSCV-SRF-VP16 were permitted to 
differentiate by replacing culture medium with those without mitogens; at 4 days 
post mitogen withdrawal we observed that SRF-VP16 not only did not was not 
sufficient to initiative differentiation but it is also slightly inhibitive for astrocyte 
differentiation (Fig. 8A,B).  However, when NPCs were induced for astrocyte 
differentiation by the addition of CNTF and LIF, we find that SRF-VP16 
substantially potentiated astrocyte differentiation in control NPCs and that it 
drives astrocyte differentiation from SRF-deficient NPCs to a comparable extent 
(Fig. 8A,B).  As with oligodendrocyte specification, we also found that SRF-VP16 
is not sufficient to induce differentiation in the absence of mitogens; unlike 
astrocyte specification, we observed that the expression of SRF-VP16 not only 
does not augment the effects of pro-oligodendrocyte factors T3 and PDGF but 
inhibits control NPC oligodendrocyte differentiation to levels comparable to SRF-
deficient NPCs (Fig. 8C, D).  Although the inhibitory effects of SRF-VP16 in 
oligodendrocyte differentiation conditions were counter-intuitive, similar negative 
effects were also found to be the case for oligodendrocyte maturation (Stritt et al., 
2009) and could occur as SRF-VP16 is not subject to the natural regulatory 
machinery that modulates the activity of wildtype SRF and/or that SRF-VP16 
maybe bound to sites/genes that interfered with the initiation of oligodendrocyte-
specific set of genes.  Given the difference influence SRF-VP16 confers on NPCs 
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between astrocyte and oligodendrocyte specification, it is likely that SRF acts 
through distinct pathways to mediate the differentiation signal transduction 
cascade for the two cell types.  In sum, our results discovered SRF as a novel 
transcriptional regulator necessary but not sufficient for astrocyte and 
oligodendrocyte differentiation in the brain.        
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Figure 8.  Constitutively active SRF is insufficient for glial specification but 
augments primed astrocyte differentiation.  (A)  Control and SRF-deficient NPCs 
were infected with either MSCV vector alone or MSCV-SRF-VP16.  NPCs were 
induced for astrocyte differentiation with CNTF and LIF or had mitogens 
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withdrawal alone (representative images not shown) permitting differentiative 
states.  Scale bar, 50 µm.  (B)  Quantification of GFAP+ astrocytes shows that by 
only withdrawing mitogens SRF-VP16 is unable to initiate astrocyte specification; 
however, when SRF-VP16 is expressed in conjunction with CNTF and LIF 
supplementation potentiates astrocyte differentiation of both control and SRF-
deficient NPCs.  (C)  Control and SRF-deficient NPCs were infected with either 
MSCV vector alone or MSCV-SRF-VP16.  NPCs were permitted for 
differentiation by mitogens withdrawal (representative images not shown) or were 
enriched for oligodendrocytes using T3 and PDGF.  Differentiated 
oligodendrocytes were identified by positive immunoreactivity for both APC and 
O4.  Scale bar, 50 µm.  (D)  Quantification for differentiated oligodendrocytes 
indicates that SRF-VP16 is not sufficient to induce oligodendrocyte specification 
in the absence of pro-oligodendrocyte factors and that it also does not potentiate 
oligodendrocyte differentiation in conjunction with T3 and PDGF.  
 
 
DISCUSSION 
Astrocytes is the most abundant cell type in the mammalian brain and 
perform critical roles in nearly every facet of brain function including 
synaptogenesis, transmitter homeostasis and synaptic plasticity (Barres, 2008; 
Allen and Barres, 2009).  Oligodendrocytes are functionally indispensable for 
higher organism nervous system as they are responsible for the generation and 
maintenance of myelin that facilitates neuronal salutatory transmission as well as  
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for providing trophic support – for example, insulin growth factor-1 (IGF-1) and 
glial cell line-derived neurotrophic factor (GDNF) – to promote the survival of 
neurons and growth of axons (Wilkins et al., 2001; Wilkins et al., 2003).  
Disruptions to oligodendrocyte development or health contributes to disorders 
such as multiple sclerosis and leukodystrophies (Baumann and Pham-Dinh, 2001). 
In this study, we found that mice with conditional deletion of SRF in 
NPCs (Srf-Nestin-cKO) exhibit deficits in astrocytes and oligodendrocyte 
specification in the brain.  In contrast, SRF deletion in neurons (Srf-NEX-cKO) 
does not affect astrocyte development suggesting a cell-autonomous role for SRF 
in astrocyte specification.  Because earlier studies had already extensively 
analyzed for the developmental effect of selective ablation of SRF in neurons and 
found SRF contributes in a paracrine fashion to modulate oligodendrocyte 
maturation (Stritt et al., 2009), we did not perform oligodendrocyte population 
studies in our Srf-NEX-cKO animals.  Cultured SRF-deficient NPCs do not 
display any defects in proliferation or exhibit increased apoptosis.  As observed in 
vivo, SRF-deficient NPCs were unable to properly differentiate into astrocytes 
and oligodendrocytes in response to pro-astrocytic and pro-oligodendrocyte 
stimuli, respectively.  Thus, our study identifies a previously unknown cell-
intrinsic role for SRF in glial cell-fate specification in the brain.   
 SRF deletion in Srf-Nestin-cKO resulted in loss of about 40% to 60% 
astrocytes and oligodendrocytes in vivo.  SRF-deficient NPCs also exhibited a 
similar failure to generate glia when induced to differentiate in vitro.   
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This could reflect a likely delay in glia specification, which is difficult to 
assess in Srf-Nestin-cKO mice since they exhibit neonatal lethality.  However, we 
found that differentiation of SRF-deficient NPCs for longer periods (until 12 days) 
in culture did not yield more astrocytes or oligodendrocytes suggesting that a 
delay in specification is unlikely to be the underlying cause of the glial deficits in 
Srf-Nestin-cKO mice (our unpublished observations).  Another possibility is that 
SRF is required for specification of a particular glial precursor cell (GPC) 
subpopulations or within a particular subpopulation for glial differentiation.  To 
date, the exact nature and identities of GPCs are poorly understood in the brain.  
Recent studies have shown that astrocytes can be generated from more than one 
precursor cell type (Liu et al., 2004; Lin and Goldman, 2009; Cai et al., 2011).  
Future studies will aim to identify these precursor subpopulations in the brains of 
Srf-Nestin-cKO mice and study their capacity to generate astrocyte and 
oligodendrocytes in the absence of SRF. 
 Recent observations have shown that SRF-deficient neurons affect 
maturation of oligodendrocyte precursors in a non-cell autonomous manner (Stritt 
et al., 2009).  In the reported Srf mouse mice, widespread SRF loss in forebrain 
neurons caused deficits in tangential neuronal migration leading to cell 
accumulation in the subventricular zone (Alberti et al., 2005).  This led to massive 
apoptosis and consequently triggered an increase in astrocytes postnatally due to 
reactive astrogliosis (Alberti et al., 2005; Stritt et al., 2009).   
 
113 
 
Chapter 3: SRF in Glial Development 
In contrast, we found that SRF ablation in developing glutamatergic 
neurons of the neocortex and hippocampus in Srf-NEX-cKO mice did not cause 
cell death or affect astrocyte differentiation even at 3 months of age.  However, 
SRF loss in NPCs alone caused a significant reduction in astrocytes both in vivo 
and in vitro.  Together, these observations strongly suggest that SRF plays a cell-
intrinsic role in regulating astrocyte specification in the brain.  Unlike other less 
than a handful of known gliogenic transcription factors identified from the spinal 
cord, such as NFIA which is necessary and sufficient (Deneen et al., 2006), we 
find that SRF is necessary but insufficient for astrocyte and oligodendrocyte 
specification. 
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Chapter 4:  Conclusions and future directions 
 This body of work stems from our interests to better understand the 
genetic programs that guide various aspects of central nervous system 
development, particularly with respect to the functional role of SRF – a highly 
evolutionary conserved, brain enriched, and stimulus-dependent transcription 
factor.  Our research began by generating a conditional mutant of SRF, in which 
deletion of the gene is driven by the Nestin promoter for NPC restriction (Srf-
Nestin-cKO), and by analyzing anatomically and histologically for cellular 
populations, cell identity and architecture abnormalities.  Because the Srf-Nestin-
cKO mutants invariably die with the first day of birth, we know that SRF must 
play certain important functional roles.  Our preliminary results show that SRF is 
important the cortical neuronal innervations in vivo as well as for glia, which 
include astrocytes and oligodendrocytes, cell-fate specification within the brain.   
Several studies have shed light on the crucial requirement of SRF for 
neurite outgrowth in culture, partly by regulating actin and growth cone dynamics 
(Ishikawa et al.; Stern et al., 2009), but our anatomical analysis is the first to shed 
light on the major neuronal projections and tracts that are affected in the absence 
of SRF (Lu and Ramanan, 2011b).  Astrocytes play multiple critical roles in brain 
development and functioning (Barres, 2008), and abnormalities in astrocyte 
development have been implicated in neurological disorders including epilepsy, 
neurodegenerative disorders and brain tumors (Lobsiger and Cleveland, 2007; 
Oberheim et al., 2008).   
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On the other hand, oligodendrocytes are essential for myelination (Hirano, 
1968; Emery, 2010), and dysregulated myelination causes multiple sclerosis and 
leukodystrophy (Emery, 2010).  Therefore, it is of critical importance to further 
elucidate the molecular and cellular mechanisms that underlie SRF-dependent 
transcription required for astrocyte and oligodendrocyte differentiation and 
development in the brain.  
 
Hints and lessons learned from Srf-Nestin-cKO mutants 
 Although the mutant brains and animals are physically indistinguishable 
from control littermates, the first striking abnormality that we observe is cerebral 
hemorrhages frequently displayed on the surface of cerebral cortex and olfactory 
bulbs.  We speculate that this could be the result of two scenarios: 1) 
compromised blood brain barrier, which consists of structural interactions 
between astrocytes and endothelial cells, and/or 2) leaky expression of the Cre 
recombinase in certain endothelial populations.  Even though the particular Nestin 
transgenic line we utilized has been selected to have highly targeted expression of 
Cre mostly in ectodermal/neural cell lineages (Tronche et al., 1999), but slight 
leaky expression was reported in certain kidney and lung cells by the vendor 
(Jackson Labs).  Non-targeted Cre-mediated deletion of SRF in a minor 
population of endothelial cells, although unverified, could have been possible.   
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Indeed, a study of SRF in endothelial cells found it to be important for 
angiogenesis and vascular integrity and the lack of SRF can result hemorrhagic 
phenotypes as well as embryonic lethality by E14.5 (Franco et al., 2008).  Despite 
that we are not fully certain of the causes of cerebral hemorrhages observed from 
our Srf-Nestin-cKO mutants at P0.5, we begun our analysis of the gross structure 
and integrity of mutant brains coronally and sagittally using Nissl staining.  We 
first noticed that mutant brains displayed enlarged ventricles as well as higher 
cellular densities at the subventricular zone (SVZ) and subgranular zone (SGZ), 
which are both regions that host precursor populations and are responsible for 
neurogenesis and gliogenesis.  However these abnormalities alone are 
inconclusive in suggesting what SRF is required developmentally.  Previous 
studies of SRF using a postnatal neuronal CaMKIIα Cre line also revealed 
increased cellular densities around the SVZ at 2 – 3 weeks of age in mutants, as a 
result of impaired tangential migration (Alberti et al., 2005).  Using 
immunohistochemistry staining against NeuN, Aldh1L1, S100β, GFAP, Olig1, 
and Olig2 expressions (cell marker for neurons, astrocytes, and oligodendrocyte 
precursors respectively), we were able to get a preliminary analysis of whether 
SRF contributes to cell-type differentiation and generation.  Quantifying for the 
number of cells per μm2 of area from microscopy images, we learned that without 
SRF the number of astrocytes as well as OPCs are reduced on a magnitude of 40 – 
60%, a result that would likely undermine the structural integrity of blood brain 
barrier as fewer astrocytes are available to reinforce  
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endothelial cells through astroglial end-feet interaction.  This loss of glia result 
was consistent across several regions that we analyzed, which include the 
neocortex (analyses were restricted to the somatosensory and motor cortex 
regions), hippocampus, striatum, and the thalamus.  A particularly interesting 
observation is that we did not observe a significant difference in neuronal 
numbers between mutant and control brains as measured by NeuN, an antibody 
that labels epitopes of mature neuronal nuclei.  This was counter-intuitive as most 
transcriptional regulators of neurogenesis or gliogenesis were founded to promote 
one lineage at the expense of another, e.g. Ngn1 which is pro-neuronal and NFIA 
which is pro-glial. 
 
Possible contributors of reduction in astrocyte and oligodendrocyte numbers 
 We hypothesized several potential causes of the decrease in glial numbers: 
1) loss of SRF elevates cell death, possibly concentrated in glial precursor 
lineages, 2) absence of SRF impaired proliferation and/or self-renewal properties 
of a population of NPCs, 3) deletion of SRF disrupted the radial migration and 
hence the ability of glia to populate the regions we examined, and 4) SRF is 
important for the differentiation of astrocytes and oligodendrocytes.  By 
employing TUNEL assay and activated-Caspase 3 staining, we analyzed for cell 
death activities at multiple stages of brain development (E14.5, E16.5, E18.5, and 
P0.5) in both control and mutants brains.   
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Although we see occasional TUNEL- or activated-Caspase 3- positive 
cells in control and mutant brain, a natural phenomenon of brain development, our 
quantification did not indicate a statistically significant different level of apoptotic 
activity in the mutant brains compared to wildtype littermates.  This is interesting 
because previous studies in ES cell cultures found that SRF may control Bcl-2 
expression, an anti-apoptotic gene, and hence promote survival during 
mesodermal differentiation (Schratt et al., 2004).  Given the discrepancy in our 
observations, we believe that SRF likely plays different functions within 
embryonic stem cells and neural stem cells.  Our results demonstrate that the 
deletion of SRF does not contribute to a higher level of cell death and that the 
reduction in glial cells is not the result of selective apoptotic activity in astrocytes 
and oligodendrocytes or their precursor lineages. 
 Next we analyzed for the abundance and integrity of radial glial cells, 
which are a type of precursor cells that also act as structural scaffolds for radial 
distribution of astrocytes, oligodendrocytes, as well as neurons (Gasser and 
Hatten, 1990; Hatten, 1990; Hatten and Mason, 1990; Jacobsen and Miller, 2003).  
By immunostaining for vimentin, an intermediate filament enriched in radial glia, 
in both P0.5 and in embryonic brains and using con-focal images to analyze for 
cyto-architectures, we did not observe a notable difference between control and 
mutant brain radial glia cells in either abundance or structural integrity.   
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Furthermore, because we did not see any defects in neuronal cortical 
layering as identified using Cux1 and Tbr2 immunostaining as well as several 
layer specific transcription factors in situ staining – including Cux2, Lmo4, and 
Lhx4, we believe that loss of SRF not only does not functionally impair radial glia 
mediated cell migration.  Together, these analyses led us to we believe that the 
deficits in glial populations in Srf-Nestin-cKO brains is not because of a radial 
migration defect. 
 By culturing NPCs as neurospheres, we also explored what the effects, if 
any, of SRF-deficiency are for precursor cell proliferation and self-renewal.  We 
cultured NPCs derived from mutants and from their control littermates at P0.5 and 
E14.5 telencephalon in the presence of EGF and FGF – mitogens that support 
NPC proliferation – for several days.  Cell samples were trypsinized and 
quantified at 12 hour intervals for measurements of growth rates of control and 
SRF-deficient NPCs.  We did not see a statistically significant difference between 
wildtype, heterozygous SRF-deficient, and homozygous SRF-deficient NPC 
cultures up to 84 hours in culture, suggesting SRF is not required for NPC 
proliferation.  Additionally, we analyzed the ability of single control and SRF-
deficient NPCs to generate secondary clonal neurospheres, a measure for stem 
cell self-renewal, and also found no difference between control and SRF-deficient 
NPCs.  These in vitro findings suggest that the removal of SRF does not impede 
the proliferative and self-renewal properties of NPCs.   
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If SRF deletion reduced the growth and renewal capacity of 
NPC/neuroepitheial cells, we would also expect to observe a change in neuronal 
numbers between control and mutant brains.  Given these findings, we do not 
think an impairment NPCs proliferation and/or self-renewal was the underlying 
cause for the reduction of astrocyte and oligodendrocyte numbers. 
 To better study differentiation, we again employed the neurosphere culture 
system, which enables us to induce and enrich for a particular cell-type.  For 
example, supplying cytokines CNTF and LIF can potently induce astrocyte 
differentiation from NPCs and providing PDGF and T3 can induce 
oligodendrocyte precursor cells (OPCs) formation as well as promote 
oligodendrocyte maturation.  Just like our cell death analyses in vivo, we do not 
see higher levels of cell death for SRF-deficient NPCs or differentiating SRF-
deficient NPCs by using both activated-Caspase3 immunostaining and propidium 
iodide staining.  On the other hand, at 2 days and 4 days post induction, we found 
statistically lower numbers of astrocytes and oligodendrocytes were generated 
from SRF-deficient NPCs, which recapitulated our in vivo findings, indicating 
that the deficits in glial numbers were the result of impaired differentiation in the 
absence of SRF.  The same results were derived when we induced astrocyte or 
oligodendrocyte differentiation with other different known cytokines or growth 
factors.  These observations suggest that SRF is necessary fundamentally for glial 
specification rather than mediating a specific signaling pathway. 
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Uncommitted SRF-deficient NPCs remain in the precursor state 
 We questioned what is the fate of SRF-deficient NPCs in mutants that 
were not becoming astrocytes or oligodendrocytes.  As we do not see an increase 
in apoptosis or conversion into neurogenesis, we suspected the majority of SRF 
deficient NPCs may remain as uncommitted precursor cells.  In culture, we tested 
this hypothesis by staining for Sox2, a marker of NPCs, in both control and SRF-
deficient samples after astrocyte induction; we found that at 4–days post induction 
there were 10 – 15% more Sox2 positive cells (as a percentage of total DAPI cells) 
in SRF-deficient cultures than control cultures.  Moreover, this roughly matched 
the decrease in the overall percentage of GFAP+ and S100β+ cells in mutant 
cultures compared to control, suggesting that cells that failed to acquire the 
astrocyte cell-fate likely just remained in the precursor state even in the presence 
of pro-astrocyte factors.  We suspect the same is likely true under oligodendrocyte 
induction but have not yet performed an experiment to confirm this.  Interestingly, 
when we followed the number of total cells from both SRF-deficient and control 
cultures over a period of 4 days, we did not see an significant increase of cell 
numbers in the mutant culture, indicating that the SRF-deficient NPCs are not 
actively proliferating under differentiative conditions and that the astrocytic 
percentage is not skewed by the expansion of NPCs populations in the mutant 
culture.   
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In order to understand whether the same findings are true in vivo, we 
analyzed the NPC population at E14.5 and E18.5 in the SVZ using 
immunostaining against Sox2 and proliferative markers Ki67 and p-Histone H3.  
Indeed, we also observed a substantial increase in the number of NPCs within the 
mutant brain, furthering indicating that many of the SRF-deficient NPCs are 
unable to acquire glial cell-fate and are stuck in the precursor state. 
 
Cellular context of SRF’s requirement for astrocyte specification 
 Having unrevealed the necessity of SRF for astrocyte and oligodendrocyte 
differentiation, we plan to study more extensively the role of SRF in astrocyte 
development first.  After obtaining a more concrete idea that the failure to 
properly generate astrocytes in the brain is the cause of reduction in the number of 
astrocytes observed in Srf-Nestin-cKO mutants at birth, we sought to better 
understand the cellular context of which SRF is necessary for astrocyte 
differentiation.  We speculated that two scenarios could take place: 1) SRF is 
required cell-autonomously such that the loss of SRF within NPCs leads to an 
impairment in astrocyte specification, and 2) SRF is required in a paracrine 
manner such that ablation of SRF in neurons causes astrocyte differentiation 
defects.  Although the majority of transcription factors have been found to 
regulate differentiation by coordinating cell-specific gene expression within a 
cell-type and are hence required cell-autonomously, neurons have been known  
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to influence the development and differentiation of astrocytes by secreting ligands, 
such as Notch ligands (Namihira et al., 2009), and that neurogenesis also precedes 
astrogenesis so that it is possible SRF-deficient neurons could be partly the cause 
of the glial developmental deficits that were observed in Srf-Nestin-cKO mutants.  
Furthermore, because SRF was reported to control oligodendrocyte maturation in 
a paracrine manner, by modulating the expression of neuronal CTGF which are 
secreted to suppressing IGF-1 signaling that promotes maturation (Stritt et al., 
2009), it is certainly possible that SRF could also regulate astrocyte development 
in a similar extrinsic manner through potentially different signaling pathways.  
Even though in neurosphere cultures we can enrich for particular cell types, we 
believe the best way to test the cellular requirement of SRF is in vivo using cell-
type specific conditional ablation of SRF.  We expanded our tool set by 
generating Srf-NEX-cKO animals, in which deletion of SRF is initiated only in 
newborn neurons in the neocortex and hippocampus starting at ~E11.5 driven by 
the basic-helix-loop-helix NEX pro-neuronal transcription factor promoter.  By 
analyzing for astrocytic populations in the Srf-NEX-cKO animals we are able to 
obtain an accurate gauge of the contribution of neuronal paracrine effect on 
astrocyte differentiation.  Unlike the Srf-Nestin-cKO mutants, Srf-NEX-cKO 
animals do not experience neonatal lethality.  We examined the astrocytes in these 
mutants as well as their control littermates at birth and in adults, using multiple 
astrocyte markers including Aldh1L1, GFAP, and S100β.   
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Quantifying immunostaining microscopy results, we found no statistically 
significant differences between control and Srf-NEX-cKO astrocyte population in 
multiple regions including the neocortex and hippocampus.  This result enabled us 
to eliminate any cell-extrinsic contribution of SRF-deficient neurons towards 
modulation of astrocyte differentiation; we conclude that SRF is necessary for 
astrocyte specification cell-autonomously. 
 
Mechanisms of how SRF control’s astrocyte differentiation 
 We know that with the aforementioned findings that we have uncovered 
novel functions of SRF within the brain, but do we know what are the underlying 
molecular mechanisms that guide these CNS developmental processes?  Earlier 
studies demonstrated that SRF is important for controlling the expression of 
cytoskeletal genes and immediate early genes (IEGs), but no established findings 
implicate that SRF is crucial for activating the expression of genes important for 
astrocyte differentiation.  To gain insights on pathways and target genes through 
which SRF regulates astrocyte differentiation, we conducted microarray analyses 
comparing differential gene expression between control and Srf-Nestin-cKO in 
hippocampi and neocortex.  We observed that several components of the Notch 
signaling pathway were expressed in lower levels in the mutant brain – including 
Notch, Hes5, Hes7, Jag1, Jag2, Dll1, and RBPjk – from our arrays.   
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We validated the microarray results by performing quantitative PCR for 
these genes on RNAs isolated from control and SRF-deficient NPCs as well as 
through western analysis of protein expression levels.  We hypothesized that SRF 
is unlikely to be modulating Notch signaling at the ligand level, because the 
addition of excess Jag1 in culture was unable to rescue differentiation impairment 
from SRF-deficient NPCs.  Using a public bioinformatics tool (Alibaba 2.1 
Transcription Binding), we found that only Notch2 – but not Notch1, Notch3, and 
Notch4 – contains a perfect SRF target CArG domain within the 5kb sequence 
upstream of the transcription start site (TSS).  We did find 1~3 near perfect SRF 
target CArG domains in the promoter region of Notch1, Notch3, and Notch4 as 
well as, however it is unclear whether these near perfect sites are functional and 
actual SRF targets.  Studies have shown SRF can transactivate certain genes via 
binding to CArG domains that mismatches by 1 to 2 nucleotides (Sun et al., 2006); 
further confirmation can be best achieved through promoter luciferase assays and 
chromatin-immunoprecipitation (ChIP) experiments.  Although, through mostly 
receptor overexpression and ligands supplementation studies, Notch signaling 
pathway was found important for astrocyte differentiation (Tanigaki et al., 2001; 
Morga et al., 2009), but the precise receptor contribution by the 4 different Notch 
receptors was not clear.  We hypothesize that SRF specifically targets the receptor 
expression of Notch2 but not others to modulate astrocyte differentiation.  We 
eliminated Notch3 as a contributing downstream gene of SRF for astrocyte 
specification because when we analyzed for astrocytic populations in null mutants  
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of Notch3 (generously provided by Kopan Lab at Washington University School 
of Medicine) no reduction in astrocyte numbers was detected at birth.  We also do 
not think Notch1 is a candidate as conditional deletion studies have shown in the 
absence of Notch1 NPC proliferation and maintenance are severely compromised 
(Ables et al.; Imayoshi et al.; Yoon and Gaiano, 2005; Corbin et al., 2008), a 
phenotype not observed in our Srf-Nestin-cKO mutants or in neurosphere cultures 
of SRF-deficient NPCs.  
 To further understand the interaction between SRF and the different Notch 
receptors, we should perform luciferase promoter analysis and chromatin-IP 
approach, in which we analyze for SRF protein binding to putative Notch CArG 
domains when induced for astrocytes in the neurosphere system.  These are 
experiments that we had planned for and are in the process of conducting.  
Despite the lack of precise transcription factor-promoter interaction insights, we 
were able to obtain Notch2f/f P0.5 animals (generously provided by Kopan Lab at 
Washington University School of Medicine) and culture their NPCs as 
neurospheres.  Using adenovirus mediated Cre recombinase knockout of Notch2 
in NPCs and inducing both control – where adenovirus containing the LacZ gene 
instead of Cre was delivered – and Notch2-deficient NPCs for astrocytes, we 
found that NPCs that lack Notch2 expression – successful knockout was 
confirmed via western blotting – showed substantial deficits for generating 
astrocytes, thus recapitulating the impairment observed in SRF-deficient NPCs.   
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These results show that SRF targets Notch2 expression and that the 
absence of Notch2 gives rise to phenotypes similar to the absence of SRF.  We 
believe it is very likely that one of the major mechanisms by which SRF regulates 
astrocyte differentiation is through the modulating of Notch2 receptor expression, 
and we have generated Nestin promoter driven conditional mutants of Notch2 
(Notch2-Nestion-cKO) to help us further understand the interactions between 
SRF and Notch2 and how they are required for astrocyte differentiation. 
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Supplementary Fig 1.  SRF regulates astrocyte differentiation through Notch2 
receptor expression.  (A)  Using quantitative PCR, we verified that the expression 
of Notch2 transcripts is indeed substantially decreased, while Notch3 is expressed 
2 – 3 fold higher in SRF-deficient NPCs.  We analyzed Notch3 null-mutant brains 
at both P0.5 and at 10 months of age and found no changes in the astrocyte 
numbers (data not shown).  (B)  We confirmed via western blotting that Notch2 
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protein expression is indeed down-regulated in SRF-deficient NPCs.  We 
hypothesize that SRF regulates astrocyte differentiation through the expression of 
Notch2 receptors.  (C)  To test this, we cultured neurospheres from control and 
Notch2f/f brains at P0.5, and used an adenovirus with Cre recombinase (Adeno-
Cre) to knockout Notch2 expression and an adenovirus with lacZ (Adeno-lacZ) as 
control.  Western blotting was employed to show that deletion of Notch2 was 
effective and that there was no consequential effect on SRF protein expression, 
suggesting SRF is upstream to Notch2.  (D)  By inducing for astrocytes, we found 
that Notch2-deficient NPCs also failed to respond to pro-astrocyte factors, 
phenocopying the differentiation impairment exhibited by the ablation of SRF. 
 
SRF is necessary but not sufficient for glial differentiation 
 Our finding is the first to demonstrate that SRF is a transcriptional factor 
necessary within the brain for glia differentiation and that re-introduction of 
wildtype SRF gene (SRFwt) via viral infection rescues the differentiation defects 
observed from the neurosphere culture assay; however, what we have not 
addressed is whether SRF-dependent transcription is sufficient for the initiation of 
astrocyte and/or oligodendrocyte differentiation.  For example, the transcription 
factor Klf15, identified from functional assays in a genome-wide screen for 
regulators of gliogenesis, was found to be sufficient for astrocyte differentiation 
within the spinal cord, activating GFAP expression (Fu et al., 2009).   
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To study whether SRF is sufficient for either astrocyte or oligodendrocyte 
specification, we made viral constructs in which the constitutively active variant 
of SRF – SRF-VP16 – was cloned into the MSCV vector (Johansen and Prywes, 
1994; Schratt et al., 2002).   
By infecting control and SRF-deficient NPCs and following the induction 
protocols that we have adopted, we discovered that in the presence of pro-
astrocyte factors SRF-VP16 augments astrocyte differentiation by giving rise to 
about 1.5 times as many GFAP-positive cells.  However, in the absence of any 
other factors that induces astrocyte differentiation, the introduction of SRF-VP16 
into either control or SRF-deficient NPCs was not sufficient to confer more 
astrocyte fate commitment than the default level observed in the absence of 
mitogens EGF and FGF.  Interestingly, the effect of SRF-VP16 is different in 
oligodendrocyte specification: in the presence of pro-oligodendrocyte factors we 
did not observe an augmented oligodendrocyte differentiation with the 
supplementation of SRF-VP16; furthermore, in the absence of mitogens and pro-
oligodendrocyte factors, SRF-VP16 was slightly inhibitive to oligodendrocyte 
cell-fate acquisition than the default level.  The inhibitive effect is indeed 
unexpected, nevertheless one that was also reported by another study (Stritt et al., 
2009).  A possible explanation for this outcome is that SRF-VP16 lacks the 
physiological trans-activation domain and is not under any normal regulatory 
control of SRF activity.   
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SRF-VP16 could be preoccupying a range of target genes – perhaps 
cytoskeletal, immediate early genes, or astrocyte-specific genes – such that when 
the epigenetic landscape is permissible for oligodendrocyte specification other 
genes promoted SRF-VP16 could be overriding the set of genes required to 
produce oligodendrocyte specific transcripts or nullifying their intended effects.   
This is a very interesting phenomenon and a question that we as well as 
other researchers of SF have little insights to.  Future studies using gene profiling 
tools to accurately capture the differential gene expression in control NPCs 
infected with SRF-VP16 or with empty vector at various time points before and 
after oligodendrocyte induction could shed more light on the underlying 
molecular interactions. 
 
 Loss of SRF in adult astrocytes leads to hypertrophy and gliosis-like 
phenotype.   
Lastly, we wanted to determine whether the astrocyte differentiation 
impairment represents a block of astrocyte commitment or a temporal delay of 
differentiation.  We generated an additional conditional knockout of SRF, within 
which SRF is deleted specifically in the astrocyte lineage (Srf-GFAP-cKO) 
(Bajenaru et al., 2002).  At P7, we found that Srf-GFAP-cKO animals shown 
normal numbers of astrocytes as determined by Aldh1L1 and GFAP 
immunostaining for astrocytes.  Surprisingly, by 4-week of age we observed a  
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4 – 6 fold increase in the number of astrocytes, as determined by both Aldh1L1 
and GFAP cell count analyses.  We found not only that there are more astrocytes 
in the adult Srf-GFAP-cKO brain, but those astrocytes are also hypertrophic.  
These observations are not the result of increased apoptosis in the mutant brain as 
we did not find elevated cell death activity measured by TUNEL staining and 
activated-caspase3 immunostaining in the same samples. 
Electron microscopy of control and Srf-GFAP-cKO brains at 4-week 
revealed that SRF-deficient astrocytes contain an greater abundance of glial 
intermediate filaments, which are up-regulated in reactive astrocytes, and are 
substantially enlarged in cell size (data not shown), resembling a reactive gliosis 
phenotype (Pekny and Nilsson, 2005).   
In summary, despite the pivotal roles that astrocytes play in the brain, the 
mechanisms that regulate their differentiation and development remain poorly 
studied.  Our findings uncovered not only that SRF is a novel cell-autonomous 
transcriptional regulator of astrocyte differentiation, but also that it plays a distinct 
functional role in modulating the development of mature astrocytes. 
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Supplementary Fig 2.  SRF loss in mature astrocytes causes hypertrophy and 
reactive-gliosis like phenotype.  (A)  Immunostaining for astrocytes using S100β 
and Aldh1L1 staining show that Srf-GFAP-cKO mutants show normal astrocyte 
numbers at 1-week after birth, however they increase significantly compared to 
control littermates at 2-week of age.  (B)  Quantification of cell counts at 1-week 
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and 2-week old brains of control and Srf-GFAP-cKO mice.  (C)  Mature 
astrocytes lacking SRF are hypertrophic and substantially more numerous at 4 
weeks after birth.  (D)  Cell count analyses show that astrocytes increase by a 
magnitude of 4 – 6 time in Srf-GFAP-cKO brains.  (E)  GFAP immunostaining 
for astrocytes in multiple regions of the brain also confirms that loss of SRF in 
adult astrocytes results enlarged cell bodies and an increase in numbers, 
resembling gliosis-like phenotypes. 
  
Neuronal projections require SRF in vivo 
 Despite mounting evidence and mechanistic insights on how SRF-
dependent transcription controls axonal outgrowth and dendritic complexity in 
vitro utilizing both cortical and hippocampus neuronal culture, little evidence 
shows what these results actually translate to in vivo, physiological influences.  
Having the Srf-Nestin-cKO and Srf-NEX-cKO conditional mutants in our tool kit, 
we are uniquely positioned to ask 1) is SRF really necessary for neuronal tracts 
and innervations in the brain, as it is possible that neurite defects of SRF are 
compensated others in the much more complex physiological environment, and 2) 
if SRF is important, what tracts and innervations truly require SRF in vivo. 
 In order address the above questions, we analyzed for anatomical 
abnormalities in the Srf-Nestin-cKO and Srf-NEX-cKO mutants using a 
combination of Nissl staining – to examine gross architecture differences, 
immunohistochemistry staining – to specifically map various neuronal 
innervations and tracts in the brain, and DiI staining – a lipophilic dye that traces  
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the processes in entirety through diffusion over time.  From coronal Nissl staining 
we first observed deficits, either absent or severely reduced, in the mutant brain in 
posterior corpus callosum, internal capsule, stria medullaris, and 
mammilothalamic tract.  This finding is interesting because it shows that SRF is 
broadly required for neuronal innervations, but it is not necessary for all because 
the anterior corpus callosum, which is innervated by different areas of cortical 
neurons compared to posterior corpus callosum (for example, somatosensory 
projections constitute a part of the anterior corpus callosum whereas visual 
cortical neuron projections constitute a part of the posterior corpus callosum), is 
still intact.  Another contributing factor for this difference could be that SRF-
deficiency results varying degree of neurite defect in different populations of 
neurons.  Future studies that compare the neurite length and number from 
different regions of neurons – for instance, surveying cortical neurons, 
hippocampal neurons, striatal neurons, and thalamic neurons – from Srf-Nestin-
cKO brains in culture could provide more insights.          
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Loss of SRF leads to impairments of major axon tracts 
 Using immunostaining for the anti-neurofilament antibody 2H3 on coronal 
and sagittal brain slices of Srf-Nestin-cKO mutants and control littermates, we 
discovered further striking deficits in axonal innervations.   
We observed a near absence of the entorhinal-hippocampal tract in the 
mutant hippocampus, substantial reduction in the cortical striatal projections, 
which relay between the neocortex and the striatum, and in the internal capsule 
innervations, and highly diminished anterior commissure as well as the fasciculus 
retroflexis in the mutant brains. 
 Because relying on immunostaining to assess the neuronal processes in the 
brain dependents on protein expressions, such as the levels of neurofilament or 
tubulin, as a proxy.  It could be possible that the loss of SRF affects neurofilament 
or other cytoskeleton protein expressions.  Thus, we applied the lipophilic 
neuronal process tracer dye DiI to visualize the entirety of the mutant neuronal 
projections compared to control brain neuronal projections.  A tiny amount of DiI 
crystals were applied on the somatosensory cortex, and after 2 – 4 weeks due to 
diffusion DiI dye could fully label the processes that extend from the region of 
crystal placement.  We observed substantial corticostriatal and corticothalamic 
innervation deficits in the Srf-Nestin-cKO brains.   
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Using ImageJ software we could accurately analyze for the projection 
length in pixels and then in micrometers; we found that these projections are 
shorter by as much as 2 – 6 folds in the mutant brains.  DiI labeling also enabled 
us to confirm again that the posterior corpus callosum and anterior commissures 
are largely absent in the mutant brain and that the thalamocortical innervations are 
highly diminished, too.  The observation that thalamocortical innervations are also 
affected in Srf-Nestin-cKO brains demonstrates that SRF is necessary for proper 
establishment of axonal tracts not only from cortical neurons but also from other 
regional neurons including thalamic neurons. 
 These results are the first to precisely pinpoint the requirement of SRF for 
several neuronal innervations and axonal tracts physiologically.  Furthermore, our 
unpublished data also show that local dendritic projections are impaired too as 
MAP2 immunostaining reveals significantly reduced apical dendritic projections 
in the mutant brain.  
 
Srf-NEX-cKO brains indicate that SRF is necessary cell-autonomously for 
several neuronal tracts establishment 
  Although it is almost intuitive to attribute the neuronal projection deficits 
to a cell-autonomous requirement for SRF, especially given that several neuronal 
culture studies find SRF-dependent transcription to be necessary for normal 
neurite genesis and outgrowth; however, to ascertain this and to study whether  
148 
 
Conclusions and future directions 
SRF-deficient glial cells could also contribute to the physiological impairments 
we turned to analyzing the Srf-NEX-cKO brains at P0.5.  By employing the same 
techniques as performed on Srf-Nestin-cKO analyses, we found that Srf-NEX-
cKO brains, which conditionally ablates SRF only in newborn neurons at around 
E11.5, also exhibit many of the same innervation and axonal tract defects.  This 
demonstrates that SRF is indeed crucial cell-autonomously for many neuronal 
projections in the brain.   
 
Could SRF control glial cell-fate specification through regulation of miRNAs? 
 Mounting evidence indicate that MicroRNAs (miRNAs) are another set of 
highly important regulator molecular entities in addition to transcription factors.  
miRNAs are capable of regulating gene expression by suppressing the translation 
of target mRNAs.  The observation that the induction of numerous, lineage-
specific miRNAs expression during neural differentiation had initiated the 
speculation that miRNAs may participate in the regulation of differentiation from 
embryonic stem (ES) cells.  Although recent studies have demonstrated important 
roles of miRNAs in neural specification, but whether miRNAs are essential 
regulators that are sufficient and/or necessary for neural differentiation or fine-
tuning modulators induced to ensure proper development is still highly debatable.  
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Transcriptional regulation and miRNA post-transcriptional modulation can work 
in concert to orchestrate cell-fate specific gene expressions (Chen and Rajewsky, 
2007). 
Studies on the most widely studied brain- and neuron-specific miR-124 
show that it promotes neuronal differentiation by directly suppressing the action 
of anti-neuronal small c-terminal domain phosphatase 1 (SCP-1) (Visvanathan et 
al., 2007) and activating alternative pre-mRNA splicing that favors neurogenesis 
via inhibition of global alternative splicing repressor, polypyrymidine tract-
binding protein 1 (PTBP1) (Makeyev et al., 2007; Makeyev and Maniatis, 2008).  
Another study showed potent influences of miR-124 with miR-9, which is also 
brain-enriched, reduced glial differentiation by decreasing the level of p-STAT3 
(Krichevsky et al., 2006). Several other brain-specific or brain-enriched miRNAs 
such as miR125b and miR-134 are also known to have profound roles in 
promoting neural differentiation by maintaining the proliferation of differentiated 
cells (Lee et al., 2005) and suppressing Nanog, which is a transcription factor 
required for ES cell self-renewal (Tay et al., 2008). 
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Research on the cardiac and smooth muscle cells have identified that SRF 
can directly regulate the expression of several miRNAs, including miRNA-1 
(Lewis et al., 2012), miRNA-21 and miRNA-143 (Horita et al., 2011), miRNA-
143/145 in vascular smooth muscle cells differentiation (Boucher et al., 2011),  
and miRNA-1, miRNA-133, and miRNA-21 in cardiac hypertrophy and 
cardiogenesis (Zhao et al., 2005; Zhang et al., 2011).  Additionally, SRF activity 
could also be a target of miRNA regulation, such as targeting by miRNA-483-5p 
in controlling the process of angiogenesis (Qiao et al., 2011).   
miRNAs are non-coding transcripts, ~22 nucleotides in length, that 
provide crucial control to gene expression by translational inhibition and 
destabilizing their target mRNAs.  They are initially transcribed as longer primary 
miRNAs (pri-miRNAs) and processed into about 70-100 nucleotides pre-miRNAs 
by Drosha and Pasha.  pre-miRNAs are translocated into the cytoplasm and 
cleaved further by Dicer, a RNase III enzyme, and loquacious, to yield mature 
miRNAs (Kloosterman and Plasterk, 2006). miRNAs recognize their 
complementary target sequences imperfectly by binding to their 3’ untranslated 
regions (UTR) and lead them to RNA-induced silencing complex (RISC) that 
prevents translation and occasionally degrades mRNAs (Kosik, 2006).  Currently, 
more than 500 human miRNA sequences are predicted to exist (Xie et al., 2005; 
Berezikov et al., 2006) and each could influence the expression of tens, if not 
hundreds, of mRNAs (Lim et al., 2005). 
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A potential future direction following up the results of this thesis could 
involve discovering and studying the interactions between SRF and its target 
miRNAs in CNS, in order to understand lineage specific differentiation control of 
SRF even though this transcription factor is expressed almost ubiquitously, and to 
study whether SRF modulates the process of cell-fate acquisition by repressing 
the expression other non-glial lineage latent transcripts through miRNAs.  
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